MCID: VLV010
MIFTS: 41

Vulvovaginitis

Categories: Reproductive diseases

Aliases & Classifications for Vulvovaginitis

MalaCards integrated aliases for Vulvovaginitis:

Name: Vulvovaginitis 12 74 54 43 15 17 71
Vulvo-Vaginitis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2273
MeSH 43 D014848
NCIt 49 C35131
SNOMED-CT 67 53277000
ICD10 32 N76.0
UMLS 71 C0042998

Summaries for Vulvovaginitis

Disease Ontology : 12 A female reproductive system disease that is characterized by inflammation of the vagina and vulva.

MalaCards based summary : Vulvovaginitis, also known as vulvo-vaginitis, is related to vaginitis and vulvitis. An important gene associated with Vulvovaginitis is HSPA4 (Heat Shock Protein Family A (Hsp70) Member 4), and among its related pathways/superpathways are CCR5 Pathway in Macrophages and Allograft rejection. The drugs Clotrimazole and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include testes, colon and skin.

Wikipedia : 74 Vaginitis, also known as vulvovaginitis, is inflammation of the vagina and vulva. Symptoms may include... more...

Related Diseases for Vulvovaginitis

Diseases related to Vulvovaginitis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 387, show less)
# Related Disease Score Top Affiliating Genes
1 vaginitis 32.9 IL10 CXCL8 CCR6 CCL5
2 vulvitis 32.3 SLC5A4 SLC5A2 ILVBL
3 candidiasis 32.0 IL10 CXCL8 CCR6
4 lichen planus 31.4 IL10 CXCL8 CCL5
5 chlamydia 31.1 IL10 HSPD1 CXCL8
6 oral lichen planus 30.6 HSPD1 HSPA4 CCL5
7 fungal infectious disease 30.6 IL10 CXCL8 CCR6 ALLC
8 pyelonephritis 30.3 IL10 CXCL8 CCL5
9 rhinitis 30.3 IL10 CXCL8 CCL5 CCL11
10 dysentery 30.3 IL10 CXCL8 CCR6
11 pustulosis of palm and sole 30.3 CXCL8 CCR6
12 genital herpes 30.3 IL10 CCR6 CCL5
13 exanthem 30.3 IL10 CXCL8 CCR6
14 toxic shock syndrome 30.2 IL10 HSPD1 CXCL8
15 conjunctivitis 30.2 IL10 CXCL8 CCL11
16 bullous pemphigoid 30.2 CXCL8 CCL5 CCL11
17 vaginal disease 30.2 IL10 CXCL8 CCR6 CCL5
18 bacterial infectious disease 30.2 IL10 HSPD1 CXCL8 CCR6
19 skin disease 30.2 IL10 HSPA4 CXCL8 CCR6 CCL11
20 allergic hypersensitivity disease 30.1 IL10 CXCL8 CCR6 CCL5 CCL11
21 dermatitis 30.1 IL10 CXCL8 CCR6 CCL11
22 dermatitis herpetiformis 30.1 IL10 CXCL8 CCL11
23 gingivitis 30.1 IL10 CXCL8 CCL5
24 keratoconjunctivitis 30.1 CXCL8 CCL5 CCL11
25 chancroid 30.1 HSPD1 CCR6
26 parasitic helminthiasis infectious disease 30.0 IL10 CCR6 CCL11
27 peritonitis 30.0 IL10 CXCL8 CCL5
28 mastitis 30.0 CXCL8 CCR6 CCL5
29 chronic mucocutaneous candidiasis 29.9 IL10 HSPA4 CCR6
30 allergic rhinitis 29.8 IL10 CXCL8 CCL5 CCL11
31 balanoposthitis 29.7 SLC5A4 SLC5A2 SLC5A1 ILVBL
32 autoimmune disease 29.5 IL10 HSPD1 CXCL8 CCR6 CCL5
33 dermatitis, atopic 29.5 IL10 CXCL8 CCR6 CCL5 CCL11
34 pulmonary disease, chronic obstructive 29.3 IL10 HSPA4 CXCL8 CCR6 CCL5 CCL11
35 balanitis 29.1 SLC5A4 SLC5A2 SLC5A1 REG1A ILVBL
36 inflammatory bowel disease 28.9 IL10 HSPD1 HSPA4 CXCL8 CCR6 CCL5
37 diabetes mellitus, type i 28.8 SLC5A4 SLC5A2 IL10 HSPD1 CXCL8 CCR6
38 diabetes mellitus 28.7 SLC5A2 REG1A IL10 HSPD1 HSPA4 CXCL8
39 acute cystitis 28.6 SLC5A4 SLC5A2 SLC5A1 REG1A IL10 CXCL8
40 vulvovaginal candidiasis 12.8
41 vulvovaginal gingival syndrome 12.4
42 vulvovaginal rhabdomyosarcoma 12.3
43 vulvovaginitis, allergic seminal 12.3
44 rare vulvovaginal tumor 12.2
45 rare non-malformative uterovaginal or vulvovaginal disease 12.2
46 vulvar disease 11.7
47 mucosal melanoma 11.7
48 vulvar vestibulitis syndrome 11.6
49 vaginal discharge 10.8
50 bacterial vaginosis 10.7
51 candida glabrata 10.7
52 trichomoniasis 10.5
53 acute transverse myelitis 10.5 IL10 CXCL8
54 mycobacterium fortuitum 10.5 HSPD1 CXCL8
55 transverse myelitis 10.5 IL10 CXCL8
56 spotted fever rickettsiosis 10.5 IL10 CCL5
57 neurosyphilis 10.4 IL10 CXCL8
58 vaginal cancer 10.4
59 sexual disorder 10.4
60 postmenopausal atrophic vaginitis 10.4
61 orofacial granulomatosis 10.4 IL10 CCL5
62 lichen sclerosus et atrophicus 10.4
63 ulceration of vulva 10.3
64 mycetoma 10.3 IL10 CXCL8 CCL5
65 primary peritoneal carcinoma 10.3 IL10 CXCL8
66 testicular sex cord-stromal neoplasm 10.3 SLC5A4 SLC5A2
67 chlamydia pneumonia 10.3 IL10 HSPD1 CXCL8
68 oral candidiasis 10.3
69 testicular leydig cell tumor 10.3 SLC5A4 SLC5A2
70 thrombophilia due to thrombin defect 10.3
71 haemophilus influenzae 10.3
72 mikulicz disease 10.3 IL10 CCR6
73 churg-strauss syndrome 10.3 IL10 CXCL8 CCL11
74 visceral leishmaniasis 10.3 IL10 HSPA4 CXCL8
75 eosinophilic pneumonia 10.3 CXCL8 CCL5 CCL11
76 overgrowth syndrome 10.3
77 allergic conjunctivitis 10.3 IL10 CXCL8 CCL11
78 vernal keratoconjunctivitis 10.3 CCL5 CCL11
79 progressive myoclonus epilepsy 8 10.3 IL10 CXCL8
80 neuritis 10.3 IL10 CXCL8 CCL5
81 inclusion body myopathy with paget disease of bone and frontotemporal dementia 10.3 IL10 HSPD1 HSPA4
82 lichen disease 10.3 IL10 CXCL8 CCR6
83 juvenile arthritis 10.3 IL10 CXCL8
84 streptococcus pneumonia 10.3 IL10 CXCL8 CCR6
85 epidemic typhus 10.3 IL10 HSPD1 CCL5
86 melanoma, cutaneous malignant 10 10.3
87 melanoma 10.3
88 cervicitis 10.3
89 severe acute respiratory syndrome 10.3 IL10 CXCL8 CCL5
90 splenic disease 10.2 IL10 HSPA4 CCR6
91 inflammatory diarrhea 10.2 SLC5A1 CXCL8
92 gingival disease 10.2 IL10 CXCL8 CCR6
93 lacrimal apparatus disease 10.2 IL10 CXCL8 CCR6
94 perinatal necrotizing enterocolitis 10.2 IL10 CXCL8 CCR6
95 middle ear disease 10.2 IL10 CXCL8 CCR6
96 osteomyelitis 10.2 IL10 CXCL8 CCL5
97 anus disease 10.2 IL10 CXCL8 CCR6
98 fanconi-like syndrome 10.2 SLC5A2 SLC5A1
99 endocarditis 10.2 IL10 HSPD1 CXCL8
100 invasive aspergillosis 10.2 IL10 CXCL8 CCR6
101 schistosomiasis 10.2 IL10 HSPA4 CCL5
102 bacterial sepsis 10.2 IL10 CXCL8 CCR6
103 primary systemic mycosis 10.2 IL10 HSPD1 CCR6
104 paranasal sinus disease 10.2 IL10 CXCL8 CCR6
105 rectal disease 10.2 IL10 CXCL8 CCR6
106 chronic fatigue syndrome 10.2 IL10 CXCL8 CCL5
107 acute disseminated encephalomyelitis 10.2 IL10 HSPD1 CCR6
108 hypersensitivity reaction type iv disease 10.2 IL10 CXCL8 CCR6
109 meningoencephalitis 10.2 IL10 CCR6 CCL5
110 ileitis 10.2 IL10 CCR6 CCL5
111 uveal disease 10.2 IL10 CXCL8 CCR6
112 folliculitis 10.2 CCR6 CCL5 CCL11
113 gastroenteritis 10.2 IL10 CXCL8 CCL11
114 stomach disease 10.2 IL10 CXCL8 CCR6
115 trypanosomiasis 10.2 IL10 CXCL8 CCL5
116 lymphadenitis 10.2 IL10 CXCL8 CCR6
117 chagas disease 10.2 IL10 CXCL8 CCL5
118 lymph node disease 10.2 IL10 HSPD1 CCR6
119 bacterial pneumonia 10.2 IL10 CXCL8 CCR6
120 trichomonas vaginalis trichomoniasis 10.2
121 vulvar intraepithelial neoplasia 10.2
122 cryptosporidiosis 10.2 HSPA4 CCL11 ALLC
123 testicular disease 10.2 IL10 HSPD1 CCR6
124 corneal disease 10.2 IL10 CXCL8 CCR6
125 autoimmune disease of musculoskeletal system 10.2 IL10 CXCL8 CCR6
126 denture stomatitis 10.2 CXCL8 ALLC
127 adrenocortical carcinoma, hereditary 10.2
128 celiac disease 1 10.2
129 adrenal cortical carcinoma 10.2
130 pollen allergy 10.2
131 thrombosis 10.2
132 bell's palsy 10.2
133 choriocarcinoma 10.2
134 adrenal cortical adenocarcinoma 10.2
135 granuloma inguinale 10.2
136 bowenoid papulosis 10.2
137 erythroplakia 10.2
138 ige responsiveness, atopic 10.2
139 immune deficiency disease 10.2
140 graft-versus-host disease 10.2
141 pelvic inflammatory disease 10.2
142 low compliance bladder 10.2
143 vulva cancer 10.2
144 rhabdomyosarcoma 10.2
145 mammary paget's disease 10.2
146 pyoderma 10.2
147 pyoderma gangrenosum 10.2
148 herpes simplex 10.2
149 chronic pain 10.2
150 nasopharyngitis 10.1 SLC5A4 SLC5A2 CCR6
151 silent myocardial infarction 10.1 SLC5A4 REG1A
152 pancreatic colloid cystadenoma 10.1 SLC5A4 SLC5A2 SLC5A1
153 status asthmaticus 10.1 IL10 CXCL8 CCL5 CCL11
154 radiculopathy 10.1 IL10 CXCL8 CCL5 CCL11
155 esophagitis 10.1 IL10 CXCL8 CCL5 CCL11
156 proteasome-associated autoinflammatory syndrome 1 10.1 IL10 CXCL8 CCL5 CCL11
157 bronchiolitis 10.1 IL10 CXCL8 CCL5 CCL11
158 bronchitis 10.1 IL10 CXCL8 CCL5 CCL11
159 pertussis 10.1 IL10 CXCL8 CCL5 CCL11
160 hypereosinophilic syndrome 10.1 IL10 CXCL8 CCL5 CCL11
161 allergic asthma 10.1 IL10 CXCL8 CCL5 CCL11
162 otitis media 10.1 IL10 CXCL8 CCL5 CCL11
163 cryptococcosis 10.1 IL10 CCR6 ALLC
164 uveitis 10.1 IL10 HSPD1 CXCL8 CCL11
165 idiopathic neutropenia 10.1 IL10 CCL5
166 parasitic protozoa infectious disease 10.1 IL10 HSPA4 CXCL8 CCR6
167 breast cancer 10.1
168 bacteriuria 10.1
169 contact dermatitis 10.1
170 leukorrhea 10.1
171 pemphigus 10.1
172 cytokine deficiency 10.1
173 stevens-johnson syndrome/toxic epidermal necrolysis 10.1
174 viral pneumonia 10.1 IL10 CXCL8 CCR6 CCL5
175 toxic megacolon 10.1 CCR6 ALLC
176 viral encephalitis 10.1 IL10 CXCL8 CCR6 CCL5
177 dacryoadenitis 10.1 IL10 CCR6
178 extrinsic allergic alveolitis 10.1 IL10 CXCL8 CCR6 CCL5
179 bone inflammation disease 10.1 IL10 CXCL8 CCR6
180 autoimmune disease of central nervous system 10.1 IL10 CXCL8 CCR6 CCL5
181 aspergillosis 10.1 IL10 CXCL8 CCR6 CCL5
182 relapsing-remitting multiple sclerosis 10.1 IL10 CXCL8 CCR6 CCL5
183 leprosy 3 10.1 IL10 HSPD1 CXCL8 CCR6
184 scabies 10.1 IL10 CXCL8 CCR6 CCL11
185 chronic conjunctivitis 10.1 IL10 CXCL8 CCR6 CCL11
186 reactive arthritis 10.1 IL10 HSPD1 CXCL8 CCR6
187 myelitis 10.1 IL10 CXCL8 CCR6 CCL11
188 gastritis 10.1 IL10 CXCL8 CCR6 CCL5
189 hyper ige syndrome 10.1 IL10 CXCL8 CCR6 CCL11
190 pulmonary eosinophilia 10.1 CXCL8 CCR6 CCL5 CCL11
191 leukocyte disease 10.1 IL10 CXCL8 CCR6 CCL11
192 mucocutaneous leishmaniasis 10.1 IL10 HSPA4
193 arteriosclerosis 10.1 IL10 HSPD1 CCL5 CCL11
194 meningitis 10.0 IL10 CXCL8 CCL5
195 pemphigus vulgaris, familial 10.0
196 paine syndrome 10.0
197 amyotrophic lateral sclerosis 3 10.0
198 severe cutaneous adverse reaction 10.0
199 erythema multiforme 10.0
200 urethritis 10.0
201 mental depression 10.0
202 cystitis 10.0
203 malignant skin fibrous histiocytoma 10.0
204 allergic contact dermatitis 10.0
205 embryonal rhabdomyosarcoma 10.0
206 enterobiasis 10.0
207 irritable bowel syndrome 10.0
208 depression 10.0
209 erythema multiforme major 10.0
210 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 10.0
211 sarcoidosis 1 10.0 HSPA4 CCR6 CCL5 CCL11
212 upper respiratory tract disease 10.0 IL10 CXCL8 CCR6 CCL11
213 viral infectious disease 10.0 IL10 CXCL8 CCR6 CCL5
214 splenic flexure cancer 10.0 SLC5A4 SLC5A2 REG1A
215 behcet syndrome 10.0 IL10 HSPD1 CXCL8 CCR6
216 pyelitis 10.0 SLC5A4 SLC5A2 CXCL8 CCR6
217 pulmonary fibrosis, idiopathic 10.0 IL10 CXCL8 CCR6 CCL5
218 opportunistic mycosis 10.0 IL10 CXCL8 CCR6 ALLC
219 pelvic organ prolapse 10.0
220 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
221 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.0
222 human immunodeficiency virus type 1 10.0
223 deficiency anemia 10.0
224 chorioamnionitis 10.0
225 anogenital venereal wart 10.0
226 diarrhea 10.0
227 urticaria 10.0
228 squamous cell carcinoma 10.0
229 constipation 10.0
230 vulvar melanoma 10.0
231 papilloma 10.0
232 endometriosis 10.0
233 proctitis 10.0
234 cellulitis 10.0
235 sertoli cell tumor 10.0
236 syphilis 10.0
237 hyperglycemia 10.0
238 acquired immunodeficiency syndrome 10.0
239 pellagra 10.0
240 crohn's disease 10.0
241 psoriasis 10.0
242 dermatophytosis 10.0
243 stomatitis 10.0
244 47,xyy 10.0
245 chronic graft versus host disease 10.0
246 rapidly involuting congenital hemangioma 10.0
247 integumentary system disease 9.9 IL10 CXCL8 CCR6
248 glucose metabolism disease 9.9 SLC5A4 SLC5A2 IL10 CCR6
249 pneumonia 9.9 IL10 HSPD1 CXCL8 CCL5 CCL11
250 acquired metabolic disease 9.9 SLC5A4 SLC5A2 IL10 CCR6
251 primary bacterial infectious disease 9.9 IL10 HSPD1 CXCL8 CCR6 CCL5
252 conjunctival disease 9.9 IL10 CXCL8 CCR6 CCL5 CCL11
253 nasal cavity disease 9.9 IL10 CXCL8 CCR6 CCL5 CCL11
254 common cold 9.9 IL10 CXCL8 CCR6 CCL5 CCL11
255 nose disease 9.9 IL10 CXCL8 CCR6 CCL5 CCL11
256 respiratory allergy 9.9 IL10 CXCL8 CCR6 CCL5 CCL11
257 bronchial disease 9.9 IL10 CXCL8 CCR6 CCL5 CCL11
258 african tick-bite fever 9.9 IL10 CCL5
259 myeloma, multiple 9.9 IL10 HSPA4 CXCL8 CCR6 CCL5
260 respiratory failure 9.9 IL10 CXCL8 CCR6 CCL5 CCL11
261 coccidiosis 9.8 IL10 HSPA4 CXCL8 CCR6 ALLC
262 eye disease 9.8 IL10 CXCL8 CCR6 CCL5 CCL11
263 fibrosis of extraocular muscles, congenital, 1 9.8
264 lipomatosis, multiple 9.8
265 paget disease, extramammary 9.8
266 suppressor of tumorigenicity 3 9.8
267 ureterocele 9.8
268 uterine anomalies 9.8
269 varicose veins 9.8
270 cystic fibrosis 9.8
271 enterocolitis 9.8
272 thymoma, familial 9.8
273 premature ovarian failure 1 9.8
274 aging 9.8
275 dermatitis herpetiformis, familial 9.8
276 alveolar soft part sarcoma 9.8
277 gastrointestinal stromal tumor 9.8
278 anxiety 9.8
279 mycobacterium tuberculosis 1 9.8
280 endometrial cancer 9.8
281 major depressive disorder 9.8
282 leukemia, acute lymphoblastic 3 9.8
283 trichosporonosis 9.8
284 fibroma 9.8
285 immunoglobulin alpha deficiency 9.8
286 estrogen-receptor positive breast cancer 9.8
287 connective tissue benign neoplasm 9.8
288 crohn's colitis 9.8
289 ectopic pregnancy 9.8
290 cutaneous candidiasis 9.8
291 mucositis 9.8
292 adenoid cystic carcinoma 9.8
293 spindle cell lipoma 9.8
294 pleomorphic lipoma 9.8
295 dermatomyositis 9.8
296 mumps 9.8
297 tonsillitis 9.8
298 osteomalacia 9.8
299 acute cervicitis 9.8
300 sarcoma 9.8
301 diphtheria 9.8
302 lyme disease 9.8
303 iron deficiency anemia 9.8
304 neutropenia 9.8
305 leukemia 9.8
306 tinea pedis 9.8
307 parametritis 9.8
308 leiomyoma 9.8
309 typhoid fever 9.8
310 endometrial stromal nodule 9.8
311 squamous cell papilloma 9.8
312 somatization disorder 9.8
313 amenorrhea 9.8
314 pleuropneumonia 9.8
315 pyuria 9.8
316 chronic cervicitis 9.8
317 angioedema 9.8
318 dermatomycosis 9.8
319 chronic cystitis 9.8
320 leiomyosarcoma 9.8
321 drug-induced hepatitis 9.8
322 autoimmune hepatitis 9.8
323 pharyngitis 9.8
324 iron metabolism disease 9.8
325 agammaglobulinemia 9.8
326 irritant dermatitis 9.8
327 glomerulonephritis 9.8
328 aspiration pneumonitis 9.8
329 botryoid rhabdomyosarcoma 9.8
330 thymoma 9.8
331 mesenchymal cell neoplasm 9.8
332 skeletal muscle cancer 9.8
333 skeletal muscle neoplasm 9.8
334 myopathy 9.8
335 spindle cell sarcoma 9.8
336 smooth muscle tumor 9.8
337 dysgerminoma 9.8
338 clear cell adenocarcinoma 9.8
339 embryoma 9.8
340 myoepithelial carcinoma 9.8
341 infertility 9.8
342 intestinal disease 9.8
343 epithelial-myoepithelial carcinoma 9.8
344 acute pyelonephritis 9.8
345 salpingitis 9.8
346 endocervicitis 9.8
347 cerebrovascular disease 9.8
348 b-cell lymphoma 9.8
349 thyroiditis 9.8
350 situs inversus 9.8
351 placenta disease 9.8
352 impetigo herpetiformis 9.8
353 impetigo 9.8
354 in situ carcinoma 9.8
355 skin melanoma 9.8
356 cervix uteri carcinoma in situ 9.8
357 pulmonary embolism 9.8
358 fasciitis 9.8
359 ischemic fasciitis 9.8
360 alopecia areata 9.8
361 alopecia 9.8
362 48,xyyy 9.8
363 autoimmune progesterone dermatitis 9.8
364 carcinoid syndrome 9.8
365 cervical intraepithelial neoplasia 9.8
366 dextrocardia with situs inversus 9.8
367 frontal fibrosing alopecia 9.8
368 guttate psoriasis 9.8
369 linear iga disease 9.8
370 precocious puberty 9.8
371 pseudobulbar affect 9.8
372 pyogenic granuloma 9.8
373 soft tissue sarcoma 9.8
374 headache 9.8
375 posttransplant acute limbic encephalitis 9.8
376 lmna-related cardiocutaneous progeria syndrome 9.8
377 vaginal atresia 9.8
378 classic pyoderma gangrenosum 9.8
379 streptococcal toxic-shock syndrome 9.8
380 commensal bacterial infectious disease 9.8 IL10 HSPD1 CXCL8 CCR6 ALLC
381 renal glucosuria 9.8 SLC5A4 SLC5A2 SLC5A1 REG1A
382 diabetes mellitus, ketosis-prone 9.8 SLC5A4 SLC5A2 SLC5A1 REG1A
383 multiple sclerosis 9.7 IL10 HSPD1 CXCL8 CCR6 CCL5 CCL11
384 hypertension, essential 9.5 SLC5A4 SLC5A2 IL10 HSPA4 CXCL8 CCL5
385 body mass index quantitative trait locus 11 9.5 SLC5A1 IL10 CXCL8 CCR6 CCL5 CCL11
386 malaria 9.5 IL10 HSPD1 HSPA4 CXCL8 CCR6 CCL5
387 diabetes mellitus, noninsulin-dependent 8.8 SLC5A4 SLC5A2 SLC5A1 REG1A IL10 HSPA4

Graphical network of the top 20 diseases related to Vulvovaginitis:



Diseases related to Vulvovaginitis

Symptoms & Phenotypes for Vulvovaginitis

Drugs & Therapeutics for Vulvovaginitis

Drugs for Vulvovaginitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 29, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Clotrimazole Approved, Vet_approved Phase 4 23593-75-1 2812
2
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
3
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
4
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
5
Tinidazole Approved, Investigational Phase 4 19387-91-8 5479
6 Anti-Infective Agents Phase 4
7 Clindamycin phosphate Phase 4
8 Anti-Bacterial Agents Phase 4
9 Clindamycin palmitate Phase 4
10 Antifungal Agents Phase 4
11 Cytochrome P-450 Enzyme Inhibitors Phase 4
12 Hormone Antagonists Phase 4
13 Hormones Phase 4
14 Anti-Infective Agents, Local Phase 4
15 Cytochrome P-450 CYP3A Inhibitors Phase 4
16 Antibiotics, Antitubercular Phase 4
17 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,... Phase 4
18 Sodium-Glucose Transporter 2 Inhibitors Phase 4
19 Hypoglycemic Agents Phase 4
20
Ketoconazole Approved, Investigational Phase 3 65277-42-1 47576
21
Terconazole Approved Phase 3 67915-31-5 441383
22
Butoconazole Approved Phase 3 64872-77-1, 64872-76-0 47472
23
acetic acid Approved Phase 3 64-19-7 176
24
Retinol acetate Phase 3 127-47-9 10245972
25 Albaconazole Investigational Phase 2 187949-02-6
26 Pharmaceutical Solutions Phase 2
27 Acidophilus
28 Estrogens
29 Anesthetics

Interventional clinical trials:

(showing 24, show less)
# Name Status NCT ID Phase Drugs
1 A National, Multi-central, Open-label, Single-arm, Phase IV Study to Evaluate Efficacy and Safety of Gynomax® XL Ovule in the Treatment of Trichomonal Vaginitis, Bacterial Vaginosis, Candidal Vulvovaginitis and Mixed Vaginal Infections Completed NCT03839875 Phase 4 Gynomax® XL Vaginal Ovule
2 Multicenter Pilot Study to Compare the Efficacy of a Combination of Vaginal Capsules With Acid Boric, L.Gasseri and L.Rhamnosus Versus the Reference Medication in Patients With Vaginal Candidiasis or Bacterial Vaginosis Completed NCT02860845 Phase 4 Antibiotic (Clindamycin);Antifungal (Clotrimazole)
3 Acute Effects of Sodium-glucose Cotransporter-2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes Not yet recruiting NCT04193566 Phase 4 Forxiga
4 Ketoconazole In Situ Gel Versus Terconazole Cream for Treatment of Vaginal Candidiasis Unknown status NCT03473418 Phase 3 Ketoconazole;Terconazole
5 Vaginal Infection Study Completed NCT00616330 Phase 3 clindamycin phosphate/butoconazole nitrate;clindamycin phosphate;butoconazole nitrate
6 Randomized Clinical Trial for Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories. Completed NCT03005353 Phase 2, Phase 3 Cumin seed extract;clotrimazole
7 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis Completed NCT03734991 Phase 3 Ibrexafungerp;Placebo
8 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (AVVC). Active, not recruiting NCT03987620 Phase 3 Ibrexafungerp;Placebo
9 Safety and Efficacy of Two Screen-and-Treat Approaches for the Prevention of Cervical Cancer Terminated NCT00233727 Phase 3
10 A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC) Completed NCT02971007 Phase 2 Oral Encochleated Amphotericin B (CAMB);Fluconazole
11 A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis Completed NCT03253094 Phase 2 Fluconazole;SCY-078
12 A Single-Blind, Randomized, Dose-Finding Study Versus Fluconazole to Assess the Efficacy and Tolerability of Five Single Doses of Albaconazole in the Treatment of Acute Non-Recurrent Candida Spp Vulvovaginitis Terminated NCT00199264 Phase 2 Albaconazole oral solution
13 A Single-Center, Open-Label, Pilot Study to Evaluate the Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis Withdrawn NCT03167957 Phase 2 Oral Encochleated Amphotericin B (CAMB);Oral Encochleated Amphotericin B (CAMB)
14 An Open-label Study to Evaluate Clinical Performance of Gedea Pessary in Adult Women With Vulvovaginal Candidiasis Completed NCT03761628
15 Maternal and Perinatal Outcome in Women With History of Premature Labor in Previous Pregnancy and Submitted to Active Search of Genital Infection Completed NCT01375439
16 Comparing NAAT Testing to Standard Methods in Diagnosis of Vaginal Infections in the General Gynecology and Vulvovaginal Referral Offices. Completed NCT02203942
17 An Open-label Study to Evaluate Clinical Performance of Gedea Pessary in Adult Women With Bacterial Vaginosis Completed NCT03762083
18 Gynaecological Disorders in Patients With Not-celiac Wheat Sensitivity Completed NCT03027492
19 Vaginal Cytokines in Postmenopausal Women With Symptoms of Vulvovaginal Irritation Completed NCT01899612
20 Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus Completed NCT03063684
21 The Use of Laser in the Treatment of Atrophic Vulvovaginitis and Its Consequent Improvement in Sexual Satisfaction Recruiting NCT04297319
22 Evaluation of Performance and Safety of the CE Marked Medical Device Class IIb Celegyn® in Vulvovaginal Atrophy (VVA): a Randomised, Double-blind, Parallel Groups, Multicentric, Placebo-Controlled, Prospective Clinical Study Recruiting NCT03823560
23 Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions Not yet recruiting NCT04219605
24 Prevention of Recurrent Vulvovaginal Candidiasis With Lactibiane Candisis 5M® Terminated NCT00915629

Search NIH Clinical Center for Vulvovaginitis

Cochrane evidence based reviews: vulvovaginitis

Genetic Tests for Vulvovaginitis

Anatomical Context for Vulvovaginitis

MalaCards organs/tissues related to Vulvovaginitis:

40
Testes, Colon, Skin, Kidney, Bone Marrow, Bone, Breast

Publications for Vulvovaginitis

Articles related to Vulvovaginitis:

(showing 1150, show less)
# Title Authors PMID Year
1
Detection of the human 70-kD and 60-kD heat shock proteins in the vagina: relation to microbial flora, vaginal pH, and method of contraception. 61 54
10231004 1999
2
Vulvovaginal atrophy (VVA) in breast cancer survivors (BCS) is still an unmet medical need: results of an Italian Delphi Panel. 61
31970513 2020
3
Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC). 61
32253071 2020
4
Vulvovaginitis and dog allergy. 61
32089402 2020
5
Improvement in glycaemic parameters using SGLT-2 inhibitor and GLP-1 agonist in combination in an adolescent with diabetes mellitus and Prader-Willi syndrome: a case report. 61
32447330 2020
6
Are probiotics an appropriate treatment option for all women? 61
32363913 2020
7
Prepubertal Vaginal Bleeding: An Inpatient Series from a Single Center in Fujian China. 61
31765797 2020
8
Prepubertal Vulvovaginitis. 61
32282354 2020
9
The use of 3 selected lactobacillary strains in vaginal probiotic gel for the treatment of acute Candida vaginitis: a proof-of-concept study. 61
32356027 2020
10
Prepubertal and Adolescent Vulvovaginitis: What to Do When a Girl Reports Vaginal Discharge. 61
32275761 2020
11
Candida africana vulvovaginitis: Prevalence and geographical distribution. 61
32317216 2020
12
Applying the Host-Microbe Damage Response Framework to Candida Pathogenesis: Current and Prospective Strategies to Reduce Damage. 61
32168864 2020
13
Vaginal discharge caused by lymphatic malformation identified by lymphoscintigraphy combined with T2-weighted magnetic resonance imaging. 61
32025595 2020
14
In vitro anticandidal potency of Syzygium aromaticum (clove) extracts against vaginal candidiasis. 61
32020877 2020
15
Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon. 61
31931738 2020
16
The role of maternal infection in preterm birth: evidence from the Brazilian Multicentre Study on Preterm Birth (EMIP). 61
32215453 2020
17
In vitro antifungal resistance profile of Candida strains isolated from Saudi women suffering from vulvovaginitis. 61
31901238 2020
18
Evaluation of Vulvovaginitis and Hygiene Habits of Women Attended in Primary Health Care Units of the Family. 61
32099484 2020
19
[Occult foreign body: A rare cause of recurrent vulvovaginitis]. 61
30482451 2020
20
Parental experiences of their child's vulvovaginitis: a qualitative interview study. 61
31451410 2019
21
Clinical and Microbiological Findings of Vulvovaginitis in Prepubertal Girls. 61
31445141 2019
22
Ultraviolet A/blue light-emitting diode therapy for vulvovaginal candidiasis: a case presentation. 61
30945022 2019
23
Streptococcal toxic shock syndrome following group A streptococcal vulvovaginitis in a breastfeeding woman. 61
31151810 2019
24
Alleviation of vulvovaginitis symptoms: can probiotics lead the treatment plan? 61
31965832 2019
25
Estimated burden of fungal infections in Sweden. 61
31376228 2019
26
Vulvovaginitis Caused by Candida Species Following Antibiotic Exposure. 61
31707496 2019
27
Myofascial Release for Vulvar Pain and Pubic Shear After a Straddle Injury in a 3-Year-Old Girl. 61
31657831 2019
28
Immunological Methods for Treatment of Vulvovaginal Infections in the Preconception Period. 61
32025255 2019
29
Celiac disease in the context of airborne allergen-associated chronic vulvo-vaginitis. 61
31599434 2019
30
Association of Ureaplasma diversum with reproductive disease in cattle. 61
31131738 2019
31
Dermatomyositis Presenting as Vulvovaginitis. 61
31306316 2019
32
Use of Dapagliflozin in the Management of Type 2 Diabetes Mellitus: A Real-World Evidence Study in Indian Patients (FOREFRONT). 61
31339784 2019
33
A pilot study of soft gel technology: a new vaginal device to improve the symptomatology of vulvovaginal atrophy in post-partum, menopause and in patients with recurrent vulvovaginitis. 61
31364105 2019
34
Transcriptomic Analysis of Streptococcus pyogenes Colonizing the Vaginal Mucosa Identifies hupY, an MtsR-Regulated Adhesin Involved in Heme Utilization. 61
31239377 2019
35
Recurrent vulvo-vaginal candidiasis in Abidjan (Côte d'Ivoire): Aetiology and associated factors. 61
31010729 2019
36
Acceptability, tolerability, and effects on symptoms and signs of vulvovaginitis of a non-soap, herbal-based intimate hygiene solution (Zelesse®). 61
31088247 2019
37
A Novel 1,3-Beta-d-Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis. 61
30885896 2019
38
Sexual violence: epidemiological and clinical aspects and circumstances of occurrence among women seen at the Gynecology-Obstetrics department of the Ignace Deen National Hospital of Conakry University Hospital. 61
31379348 2019
39
Impact of the Sampling Site in the Result of Wet Mount Microscopy. 61
30907778 2019
40
Vulvovaginal Discomfort Is Common in Both Premenopausal and Postmenopausal Women. 61
30741753 2019
41
Amebic Infection of the Female Genital Tract: A Report of Three Cases. 61
31391760 2019
42
Alternative and complementary therapies for vulvovaginal candidiasis. 61
30269301 2019
43
Candida glabrata Fungemia Following Robotic Total Laparoscopic Hysterectomy and Bilateral Salpingo-oophorectomy in a Patient with Recurrent Vulvovaginitis: A Case Report. 61
31187014 2019
44
50 Years Ago in The Journal of Pediatrics: Vulvovaginitis in the Premenarcheal Child. 61
30798826 2019
45
In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis. 61
30478163 2019
46
Biofilms and vulvovaginal candidiasis. 61
30447520 2019
47
Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitors. 61
30207042 2019
48
Erosive Vulvovaginitis Associated With Borrelia burgdorferi Infection. 61
31043089 2019
49
Chronic vulvovaginitis caused by Candida dubliniensis in an immunologically competent adult female. 61
30170531 2019
50
Youth-Onset Type 2 Diabetes Manifestations in other Specialties: Its Many Disguises. 61
31096219 2019
51
Periodontal disease: Repercussions in pregnant woman and newborn health-A cohort study. 61
31756178 2019
52
Health care utilization and costs following amplified versus non-amplified molecular probe testing for symptomatic patients with suspected vulvovaginitis: a US commercial payer population. 61
30863131 2019
53
Disorders of vulva and vagina in children and adolescent. 61
30650979 2018
54
Intravaginal boric acid: is it an alternative therapeutic option for vaginal trichomoniasis? 61
29223972 2018
55
Sexual behaviour and extra-genital colonisation in women treated for recurrent Candida vulvo-vaginitis. 61
29998617 2018
56
Is multiple-site colonization with Candida spp. related to inadequate response to individualized fluconazole maintenance therapy in women with recurrent Candida vulvovaginitis? 61
30293562 2018
57
An Update on the Roles of Non-albicansCandida Species in Vulvovaginitis. 61
30384449 2018
58
Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil. 61
29908032 2018
59
Vulval lichen planus-lichen sclerosus overlap. 61
29490571 2018
60
The Relationship Between Vulvovaginal Candidiasis and Provoked Vulvodynia: A Systematic Review. 61
30145093 2018
61
Efficacy, acceptability and tolerability of Zelesse® for the treatment of non-specific vulvovaginitis in paediatric patients: The NINESSE Study. 61
29877120 2018
62
Molecular characterization and virulence of an alphaherpesvirus isolated from a BoHV1 gB-seropositive and gE-seronegative Italian buffalo. 61
29981704 2018
63
Spontaneous resolution of labial adhesions in pre-pubertal girls. 61
29436045 2018
64
Prepubertal vulvovaginitis. 61
29970369 2018
65
National surveillance plan for infectious bovine rhinotracheitis (IBR) in autochthonous Italian cattle breeds: Results of first year of activity. 61
29778188 2018
66
Psoriasin, a novel anti-Candida albicans adhesin. 61
29736603 2018
67
Parapoxviral vulvovaginitis in Holstein cows. 61
29429402 2018
68
Vulvovaginitis- presentation of more common problems in pediatric and adolescent gynecology. 61
28927766 2018
69
Nerve Growth Factor and Selected Cytokines in Women With and Without Vulvodynia. 61
29570566 2018
70
Effect of 2-Phenylethanol as Antifungal Agent and Common Antifungals (Amphotericin B, Fluconazole, and Itraconazole) on Candida Species Isolated from Chronic and Recurrent Cases of Candidal Vulvovaginitis. 61
29658789 2018
71
Differentiation of bovine herpesvirus1 subtypes based on UL0.5 gene sequencing. 61
29607367 2018
72
An unusual presentation of pseudocowpox associated with an outbreak of pustular ulcerative vulvovaginitis in a Swedish dairy herd. 61
29153035 2018
73
First report of Vulvovaginitis due to Cryptococcus magnus in Iran. 61
30186991 2018
74
Pediatric Resident Training in Prepubertal Vulvar Conditions. 61
28919147 2018
75
Bovine herpesvirus-1 in three major milk sheds of Ethiopia: Serostatus and association with reproductive disorders in dairy cattle. 61
29406079 2018
76
Cyproterone acetate in the treatment of oestrogen hypersensitivity vulvovaginitis. 61
28718897 2018
77
Natural Products for Vulvovaginal Candidiasis Treatment: Evidence from Clinical Trials. 61
30277156 2018
78
Spontaneous Massive Vulvar Edema in Pregnancy: A Case Report. 61
30402312 2018
79
Vaginal microbiome. 61
30848142 2018
80
A nested-PCR strategy for molecular diagnosis of mollicutes in uncultured biological samples from cows with vulvovaginitis. 61
29191491 2018
81
Epidemiological Features and Antibiotic Resistance Patterns of Haemophilus influenzae Originating from Respiratory Tract and Vaginal Specimens in Pediatric Patients. 61
28629795 2017
82
Management of mycoses in daily practice. 61
29050446 2017
83
Evaluation of esterase and hemolysin activities of different Candida species isolated from vulvovaginitis cases in Lorestan Province, Iran. 61
29707672 2017
84
Identification of Candida species isolated from vulvovaginitis using matrix assisted laser desorption ionization-time of flight mass spectrometry. 61
29707675 2017
85
Disease Pattern among Children attending Pediatric Outpatient Department in Community Based Medical College Hospital, Bangladesh. 61
29208876 2017
86
A novel bovine papillomavirus type in the genus Dyokappapapillomavirus. 61
28616671 2017
87
Histopatology of the reproductive tract of Nellore pubertal heifers with genital ureaplasmosis. 61
29236848 2017
88
Candida Vulvovaginitis and Vulvodynia: The Mystery Continues. 61
28836889 2017
89
A review of paediatric and adolescent gynaecology services in a tertiary outpatient clinic. 61
28152641 2017
90
Molecular Identification and Antifungal Susceptibility Pattern of Non-albicans Candida Species Isolated from Vulvovaginal Candidiasis 61
28688376 2017
91
Assessment of cow and farm level risk factors associated with Ureaplasma diversum in pasture-based dairy systems - A field study. 61
28876387 2017
92
Haemophilus influenzae vulvovaginitis associated with rhinitis caused by the same clone in a prepubertal girl. 61
28621044 2017
93
Comparison of enzymatic activities in different Candida species isolated from women with vulvovaginitis. 61
28236530 2017
94
Effectiveness of Ageratina pichinchensis Extract in Patients with Vulvovaginal Candidiasis. A Randomized, Double-Blind, and Controlled Pilot Study. 61
28299831 2017
95
Risk Factors and Risk Stratification for Adverse Obstetrical Outcomes After Appendectomy or Cholecystectomy During Pregnancy. 61
28114513 2017
96
[COMBINED IMMUNOTHERAPY OF RECONDITIONAL CHRONIC NON-SPECIFIC VULVOVAGINITIS IN IMMUNOCOMPROMISED GIRLS]. 61
28628017 2017
97
Clinical presentation, diagnosis and treatment of vulvovaginitis in girls: a current approach and review of the literature. 61
28083751 2017
98
[Allergy to human seminal plasma]. 61
28722364 2017
99
Prevalence of Candida albicans, Candida dubliniensis and Candida africana in pregnant women suffering from vulvovaginal candidiasis in Argentina. 61
28385421 2017
100
Streptococcus pyogenes as the cause of vulvovaginitis and balanitis in children. 61
27638252 2017
101
Vulvar Lichen Sclerosus et Atrophicus. 61
28706405 2017
102
Comorbidity profiles among women with postcoital bleeding: a nationwide health insurance database. 61
28246983 2017
103
Current practice patterns for management of vulvodynia in the United States. 61
28000024 2017
104
Author's reply to comment on: is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504). 61
27988816 2017
105
Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504). 61
28025698 2017
106
Vulvovaginitis: Find the cause to treat it. 61
28322677 2017
107
Candida vulvovaginitis: A store with a buttery and a show window. 61
27687503 2017
108
Presence of Ureaplasma diversum in the genital tracts of female dairy cattle in Mato Grosso State, Brazil. 61
27915439 2017
109
Immunobiological Activity of Synthetically Prepared Immunodominant Galactomannosides Structurally Mimicking Aspergillus Galactomannan. 61
29081774 2017
110
Anti-Inflammatory Activity of Babassu Oil and Development of a Microemulsion System for Topical Delivery. 61
29430254 2017
111
Clinical Significance and Characteristic Clinical Differences of Cytolytic Vaginosis in Recurrent Vulvovaginitis. 61
27300413 2017
112
Characterization and identification of microbial communities in bovine necrotic vulvovaginitis. 61
28093107 2017
113
Role of Molecular Biology in Diagnosis and Characterization of Vulvo-Vaginitis in Clinical Practice. 61
29017160 2017
114
Prevalence of individual and bulk tank milk antibodies of bovine herpesvirus type 1 and its relation to milk quality parameters on dairy farms in Catalonia (north-east Spain). 61
28761669 2017
115
Stratum corneum lipid liposome-encapsulated panomycocin: preparation, characterization, and the determination of antimycotic efficacy against Candida spp. isolated from patients with vulvovaginitis in an in vitro human vaginal epithelium tissue model. 61
28831255 2017
116
Molecular identification and antifungal susceptibility profile of Candida species isolated from patients with vulvovaginitis in Tehran, Iran. 61
29387119 2017
117
Antimicrobial Potential of Rosmarinus officinalis Commercial Essential Oil in the Treatment of Vaginal Infections in Pregnant Women. 61
30549845 2017
118
Vulvovaginitis and diabetes. 61
28065975 2017
119
Clinical Recommendation: Vulvovaginitis. 61
27969009 2016
120
Overexpression of MDR-1 and CDR-2 genes in fluconazole resistance of Candida albicans isolated from patients with vulvovaginal candidiasis. 61
28959792 2016
121
Prevalence of Bovine herpesvirus type 4 in aborting dairy cows. 61
28092611 2016
122
Does the North American Society for Pediatric and Adolescent Gynecology Short Curriculum Increase Resident Knowledge in Pediatric and Adolescent Gynecology? 61
27216709 2016
123
Dual crosslinked iminoboronate-chitosan hydrogels with strong antifungal activity against Candida planktonic yeasts and biofilms. 61
27516277 2016
124
Complete genomic sequence and comparative analysis of four genital and respiratory isolates of bovine herpesvirus subtype 1.2b (BoHV-1.2b), including the prototype virus strain K22. 61
27568014 2016
125
The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model. 61
27796932 2016
126
Common prepubertal vulvar conditions. 61
27517340 2016
127
Distribution and Drug Susceptibility of Candida spp. Associated With Female Genital Tract Infection, Chongqing, China. 61
28138369 2016
128
Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504). 61
27393491 2016
129
Phospholipase and proteinase activities of Candida spp. isolates from vulvovaginitis in Iran. 61
27544321 2016
130
A case of metronidazole-resistant Trichomonas vaginalis in pregnancy. 61
26384945 2016
131
Bovine herpesvirus-1: Genetic diversity of field strains from cattle with respiratory disease, genital, fetal disease and systemic neonatal disease and their relationship to vaccine strains. 61
27374060 2016
132
Estimated burden of fungal infections in Kenya. 61
27580321 2016
133
A prospective observational study of vulvovagintis in pregnant women in Argentina, with special reference to candidiasis. 61
26931504 2016
134
Candida nivariensis as a New Emergent Agent of Vulvovaginal Candidiasis: Description of Cases and Review of Published Studies. 61
26708316 2016
135
Personal Hygiene and Vulvovaginitis in Prepubertal Children. 61
26187769 2016
136
Feminine hygiene practices among female patients and nurses in Lebanon. 61
27215916 2016
137
Skin infections in pregnancy. 61
27265075 2016
138
Susceptibility and molecular characterization of Candida species from patients with vulvovaginitis. 61
26991298 2016
139
Affirm VPIII microbial identification test can be used to detect gardnerella vaginalis, Candida albicans and trichomonas vaginalis microbial infections in Korean women. 61
26787446 2016
140
Dhatakyadi Varti - An effective local treatment for Upapluta Yonivyapad (vulvovaginitis during pregnancy): A standard controlled randomized clinical trial. 61
29200747 2016
141
Clinical and microbiologic characteristics of vulvovaginitis in Korean prepubertal girls, 2009-2014: a single center experience. 61
27004204 2016
142
Urinary and genital infections in patients with diabetes: How to diagnose and how to treat. 61
26323665 2016
143
High Prevalence of Sexual Dysfunction in a Vulvovaginal Specialty Clinic. 61
25259664 2016
144
Non-albicans Candida Vulvovaginitis: Treatment Experience at a Tertiary Care Vaginitis Center. 61
26083330 2016
145
Recurrent desquamative vulvovaginitis in a young woman. 61
26266812 2016
146
Safety, efficacy, and tolerability of differential treatment to prevent and treat vaginal dryness and vulvovaginitis in diabetic women. 61
27132409 2016
147
Theriogenology Question of the Month. Vulvovaginitis or uterine, cervical, or vaginal neoplasia. 61
26642128 2015
148
Vaginitis Caused by Corynebacterium amycolatum in a Prepubescent Girl. 61
26324578 2015
149
Streptococcal vulvovaginitis in adults: Not a rare entity. 61
26515866 2015
150
Classification of Hypertrophy of Labia Minora: Consideration of a Multiple Component Approach. 61
26680395 2015
151
Guttate Psoriasis Following Streptococcal Vulvovaginitis in a Five-year-old Girl. 61
26024939 2015
152
Tethered Cord Syndrome in the Pediatric-Adolescent Gynecologic Patient. 61
26092705 2015
153
Prevalence of vulvovaginitis and relation to physical findings in girls assessed for suspected child sexual abuse. 61
26294142 2015
154
Sodium-glucose cotransport inhibitors: mechanisms, metabolic effects and implications for the treatment of diabetic patients with chronic kidney disease. 61
25230708 2015
155
Successful treatment of refractory Trichomonas vaginalis infection using intravenous metronidazole. 61
25161176 2015
156
[The role of the symptomatic and asymptomatic sexual partners in the recurrent vulvovaginitis]. 61
26247251 2015
157
Phenotypic characterization and adhesive properties of vaginal Candida spp. strains provided by the CHU Farhat Hached (Sousse, Tunisia). 61
25618183 2015
158
Estimating the Burden of Fungal Diseases in Israel. 61
26233998 2015
159
The Role of PCR in the Diagnosis of Candida Vulvovaginitis-a New Gold Standard? 61
26003471 2015
160
Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis. 61
25881537 2015
161
[Bovine herpesvirus 4 (BoHV-4): general aspects of the biology and status in Argentina]. 61
25962539 2015
162
The Comparison of vaginal cream of mixing yogurt, honey and clotrimazole on symptoms of vaginal candidiasis. 61
26153168 2015
163
Isolation of different species of Candida in patients with vulvovaginal candidiasis from sari, iran. 61
26034533 2015
164
Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis). 61
25711406 2015
165
Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. 61
26001874 2015
166
[VESICOURETERAL REFLUX INTO SMALL KIDNEY DIAGNOSTIC AND THERAPEUTIC PARADIGM]. 61
26237814 2015
167
Humoral immune responses to Candida albicans complement receptor 3-related protein in the atopic subjects with vulvovaginal candidiasis. Novel sensitive marker for Candida infection. 61
25673750 2015
168
[Use of probiotics and prebiotics in primary care]. 61
25659055 2015
169
[Management of vaginal infection following failure of a probabilistic treatment: is the vaginal swab really useful?]. 61
25595944 2015
170
[Yeast species in vulvovaginitis candidosa]. 61
25544052 2015
171
The prevalence of abnormal genital findings, vulvovaginitis, enuresis and encopresis in children who present with allegations of sexual abuse. 61
25127358 2014
172
Recurrent Streptococcus pyogenes genital infection in a woman: test and treat the partner! 61
25449232 2014
173
Altered perineal microbiome is associated with vulvovaginitis and urinary tract infection in preadolescent girls. 61
25435916 2014
174
[Microbiological study of vulvovaginitis in prepubertal girls]. 61
25536432 2014
175
Safety profile of dapagliflozin for type 2 diabetes: pooled analysis of clinical studies for overall safety and rare events. 61
25096959 2014
176
Dermatosis associated with menopause. 61
25540566 2014
177
Epidemiology and antifungal susceptibilities of yeasts causing vulvovaginitis in a teaching hospital. 61
25005365 2014
178
A systematic review of the effect of daily panty liner use on the vulvovaginal environment. 61
25128928 2014
179
Recurrent vulvovaginitis. 61
25220102 2014
180
Epidemiology and control of bovine herpesvirus 1 infection in Europe. 61
24954868 2014
181
Ureaplasma diversum as a cause of pustular vulvovaginitis in bovine females in Vale Guapore, Mato Grosso State, Brazil. 61
24817480 2014
182
Dapagliflozin added to usual care in individuals with type 2 diabetes mellitus with preexisting cardiovascular disease: a 24-week, multicenter, randomized, double-blind, placebo-controlled study with a 28-week extension. 61
24890683 2014
183
Prevalence and risk factors of pelvic pain. 61
24206627 2014
184
Aetiologies and contributing factors of vulvovaginal candidiasis in Abidjan (Cote d'Ivoire). 61
24387809 2014
185
Phenotypic Characterization and Antifungal Susceptibility Pattern to Fluconazole in Candida species Isolated from Vulvovaginal Candidiasis in a Tertiary Care Hospital. 61
24995172 2014
186
Neonatal leukemoid reaction associated with Candida albicans chorioamnionitis. 61
24730633 2014
187
Non-infectious inflammatory genital lesions. 61
24559568 2014
188
Ureaplasmas and mycoplasmas in vaginal samples from prepubertal girls and the reasons for gynecological consultation. 61
24268557 2014
189
Vulvovaginitis in a pediatric population: relationship among etiologic agents, age and Tanner staging of breast development. 61
24566785 2014
190
Marked improvement of vulvovaginitis of unknown origin in a pediatric patient--case report. 61
25551972 2014
191
Microbiological findings of vulvovaginitis in prepubertal girls. 61
24191064 2014
192
Congenital candidiasis as a subject of research in medicine and human ecology. 61
25281815 2014
193
The value of simple microbiological studies for on-site screening of acute neonatal conjunctivitis in Angola. 61
24460893 2014
194
Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition. 61
23760143 2014
195
Chronic pelvic pain in Spanish women: prevalence and associated risk factors. A cross-sectional study. 61
24992769 2014
196
Observational study of Streptococcus pyogenes isolated from vaginal swabs of adult women in a hospital and community laboratory. 61
24247626 2013
197
[Acute bacterial meningitis by Streptococcus agalactiae in a non pregnant woman associated to a cerebrospinal fluid leak: a case report]. 61
24522313 2013
198
Vulvo-vaginitis in prepubertal girls: new ways of administering old drugs. 61
24012128 2013
199
The utility of transrectal ultrasound in adolescents when transabdominal or transvaginal ultrasound is not feasible. 61
23849089 2013
200
Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin. 61
23806570 2013
201
Comparing the effects of low-dose contraceptive pills to control dysfunctional uterine bleeding by oral and vaginal methods. 61
24353721 2013
202
Recurrent vaginal discharge in children. 61
22264471 2013
203
[Gonococcal vulvovaginitis in prepubertal girls: sexual abuse or accidental transmission?]. 61
23856383 2013
204
Bovine herpes virus-1 (BoHV-1) in cattle-a review with emphasis on reproductive impacts and the emergence of infection in Ireland and the United Kingdom. 61
23916092 2013
205
Association of pregnancy and Candida vaginal colonization in women with or without symptoms of vulvovaginitis. 61
23689173 2013
206
Vaginal douching by women with vulvovaginitis and relation to reproductive health hazards. 61
23672530 2013
207
Acute cervicitis and vulvovaginitis may be associated with Cytomegalovirus. 61
23606387 2013
208
Emergence of non-albicans Candida among candidal vulvovaginitis cases and study of their potential virulence factors, from a tertiary care center, North India. 61
24056652 2013
209
Presence of Ureaplasma diversum in the Australian cattle population. 61
23438461 2013
210
Female-specific pruritus from childhood to postmenopause: clinical features, hormonal factors, and treatment considerations. 61
23551372 2013
211
[Gonococcal vulvovaginitis in prepubertal girls: sexual abuse or accidental transmission?]. 61
23219271 2013
212
Effects of different extracts of Eucalyptus camaldulensis on Trichomonas vaginalis parasite in culture medium. 61
24516847 2013
213
[Statement of the Polish Gynecological Society Expert Group on the use of Macmiror Complex 500]. 61
23488303 2012
214
Fluconazole-resistant Candida albicans vulvovaginitis. 61
23168767 2012
215
Chronic vulvovaginal candidiasis: what we know and what we have yet to learn. 61
22998230 2012
216
[Study of blood flow improvement of topical application of estrogen on low genitourinary tract and its safety]. 61
23290168 2012
217
Quantification of normal vaginal constituents using a new wet preparation technique. 61
22968057 2012
218
Biofilm production by Candida: comparison of bloodstream isolates with cervical isolates. 61
23997348 2012
219
Microbiological aspects of vulvovaginitis in prepubertal girls. 61
22383074 2012
220
Comparison of clinical and microbiological features of vulvovaginitis in prepubertal and pubertal girls. 61
22817817 2012
221
Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society. 61
22519657 2012
222
Targeting renal glucose reabsorption for the treatment of type 2 diabetes mellitus using the SGLT2 inhibitor dapagliflozin. 61
22913895 2012
223
Polymerase chain reaction for detection of Ureaplasma diversum from urogenital swabs in cattle in Australia. 61
22731950 2012
224
Congenital cutaneous candidiasis in two full-term infants. 61
21906141 2012
225
The role of cystovaginoscopy and hygienic advice in girls referred for symptoms of vulvovaginitis. 61
22294671 2012
226
Use of Dermasilk briefs in recurrent vulvovaginal candidosis: safety and effectiveness. 61
21895786 2012
227
Vulvovaginitis candidiasis recurrence during pregnancy. 61
24199471 2012
228
The effects of bovine necrotic vulvo-vaginitis on reproductive and production performance of Israeli 1st calf heifers. 61
22225696 2012
229
Identification of immune cells by flow cytometry in vaginal lavages from women with vulvovaginitis and normal microflora. 61
22151521 2012
230
Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin. 61
22238392 2012
231
Evaluation of sexual function in Brazilian women with recurrent vulvovaginal candidiasis and localized provoked vulvodynia. 61
22214370 2012
232
Eggs containing larvae of Enterobius vermicularis in vaginal smear. 61
22438633 2012
233
Chronic vulvovaginitis in women older than 50 years: analysis of a prospective database. 61
21964206 2012
234
Alpha and gamma herpesvirus detection in two herds of farmed red deer (Cervus elaphus) in New Zealand. 61
22175434 2012
235
Vaginal use of Ibuprofen isobutanolammonium (ginenorm): efficacy, tolerability, and pharmacokinetic data: a review of available data. 61
22844609 2012
236
Fluconazole susceptibility and ERG11 gene expression in vaginal candida species isolated from Lagos Nigeria. 61
22493755 2012
237
Prevalence and risk factors for bacterial vaginosis and other vulvovaginitis in a population of sexually active adolescents from Salvador, Bahia, Brazil. 61
23133306 2012
238
Vulvovaginitis and other common vulvar disorders in children. 61
22846522 2012
239
A study of some infectious causes of reproductive disorders in cattle owned by resource-poor farmers in Gauteng Province, South Africa. 61
22616434 2011
240
Characterization of patients with suspected seminal plasma hypersensitivity. 61
22221443 2011
241
Vaginal douching practice and related symptoms in a rural area of Turkey. 61
21153831 2011
242
[The usefulness of combined gynecologic and endocrinologic consultation in pediatrics: a retrospective study of the reasons for consultation and the practical approach]. 61
22216731 2011
243
Vulvovaginal candidiasis in Mato Grosso, Brazil: pregnancy status, causative species and drugs tests. 61
24031756 2011
244
[Importance of studying the balance of vaginal content (BAVACO) in the preventive control of sex workers]. 61
22274820 2011
245
Saccharomyces cerevisiae vaginitis: microbiology and in vitro antifungal susceptibility. 61
21424705 2011
246
Age of sexual debut and central introital dyspareunia. 61
21703751 2011
247
Modulation of morphogenesis in Candida albicans by various small molecules. 61
21642508 2011
248
Voiding dysfunction: another etiology of vulvovaginitis in young girls. 61
21600807 2011
249
Group A streptococcal vaginitis: an unrecognized cause of vaginal symptoms in adult women. 61
21336834 2011
250
Vaginal flora changes on Pap smears after insertion of levonorgestrel-releasing intrauterine device. 61
21397094 2011
251
The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population. 61
21194828 2011
252
Severe vulvovaginitis as a presenting problem of type 2 diabetes in adolescent girls: a case series. 61
21402639 2011
253
Vulvovaginitis and other common childhood gynaecological conditions. 61
21119021 2011
254
Clinical antibiotic response of mycoplasma and ureaplasma in patients with symptomatic recurrent vulvovaginal colonization. 61
21542531 2011
255
Comparative analysis of replication characteristics of BoHV-1 subtypes in bovine respiratory and genital mucosa explants: a phylogenetic enlightenment. 61
21324115 2011
256
Quantitative evaluation of biofilm formation in yeast nitrogen base (YNB) broth and in bovine serum (BS) of Candida albicans strains isolated from mucosal infections. 61
21682096 2011
257
Patient preferences and treatment safety for uncomplicated vulvovaginal candidiasis in primary health care. 61
21281464 2011
258
[Management of side effects of targeted therapies in renal cancer: sexual disorders]. 61
25819122 2011
259
Antimicrobial topical agents used in the vagina. 61
21325838 2011
260
[Effect of combined therapy using complex of natural cytokines and antimicrobial peptides in urogenital infections caused by Chlamydia and Mycoplasma]. 61
21446174 2011
261
A new approach in the first-line treatment of bacterial and mycotic vulvovaginitis with topical lipohydroperoxides and glycyrrhetic acid: a comparative study. 61
21995156 2011
262
A study of paediatric and adolescent gynaecology services in a British district general hospital. 61
21078058 2010
263
Relationship between infectious agents for vulvovaginitis and skin color. 61
21308158 2010
264
Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1). 61
20800678 2010
265
Sexually transmitted diseases during pregnancy: a synthesis of particularities. 61
21308300 2010
266
Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New Insights. 61
21308556 2010
267
Diagnosis of vulvovaginitis: comparison of clinical and microbiological diagnosis. 61
20461391 2010
268
In vitro profiling of pramiconazole and in vivo evaluation in Microsporum canis dermatitis and Candida albicans vaginitis laboratory models. 61
20805398 2010
269
Desquamative inflammatory vaginitis: differential diagnosis and alternate diagnostic criteria. 61
20885157 2010
270
Recrudescent herpes labialis mimicking primary herpes labialis in pregnancy. 61
22558555 2010
271
Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China. 61
20516286 2010
272
Education key in tackling childhood constipation. 61
20812610 2010
273
Chronic vulvitis in pre-pubertal girls. 61
20546218 2010
274
Vulvovaginitis in childhood. 61
19884044 2010
275
Correlation of Trichomonas vaginalis to bacterial vaginosis: a laboratory-based study. 61
20351456 2010
276
Automated microscopy, dipsticks and the diagnosis of urinary tract infection. 61
19815534 2010
277
Vaginal microbiocoenosis and cytology of prepubertal and adolescent girls: their role in health and disease. 61
20143208 2010
278
[Frequency of Haemophilus spp. in urinary and and genital tract samples]. 61
20387727 2010
279
Management of recurrent vulvo-vaginal candidosis as a chronic illness. 61
21051852 2010
280
[Vulvovaginitis in young girls]. 61
20120939 2009
281
Does long-term talc exposure have a carcinogenic effect on the female genital system of rats? An experimental pilot study. 61
19301023 2009
282
Candida glabrata: an emergent opportunist in vulvovaginitis. 61
20433786 2009
283
Malignant edema in postpartum dairy cattle. 61
19901305 2009
284
Azole resistant Candida glabrata vulvovaginitis treated with boric acid. 61
19619928 2009
285
Granular Vulvovaginitis Syndrome in Nelore pubertal and post pubertal replacement heifers under tropical conditions: role of Mycoplasma spp., Ureaplasma diversum and BHV-1. 61
19319656 2009
286
Prevalence of bacterial vaginosis and impact of genital hygiene practices in non-pregnant women in zanjan, iran. 61
22216382 2009
287
Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis. 61
19543144 2009
288
Can vaginal pH be measured from the wet mount slide? 61
19643525 2009
289
Use of the VS-sense swab in diagnosing vulvovaginitis. 61
19743911 2009
290
Identification of Mycoplasma bovigenitalium and Mycoplasma canadense from outbreaks of granulopapular vulvovaginitis in dairy cattle in Israel. 61
19749209 2009
291
Pediatric vulvovaginal disorders: a diagnostic approach and review of the literature. 61
19941710 2009
292
Morphological, biochemical and molecular characterisation of the first Italian Candida africana isolate. 61
18983430 2009
293
Long-term symptomatic group B streptococcal vulvovaginitis: eight cases resolved with freshly cut garlic. 61
19552998 2009
294
Association between group A beta-haemolytic streptococci and vulvovaginitis in adult women: a case-control study. 61
19343383 2009
295
Infertility and venereal disease in cattle inseminated with semen containing bovine herpesvirus type 5. 61
19633324 2009
296
Investigation of the sensitivity of a cross-polarized light visualization system to detect subclinical erythema and dryness in women with vulvovaginitis. 61
19393601 2009
297
Streptococcal vulvovaginitis. 61
19539842 2009
298
Gynecological disorders in geriatric emergency medicine. 61
19246559 2009
299
Bovine herpes virus infections in cattle. 61
19558751 2009
300
Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes. 61
19223627 2009
301
Cervid herpesvirus 2 causes respiratory and fetal infections in semidomesticated reindeer. 61
19279181 2009
302
Rate of preterm births in pregnant women with common lower genital tract infection: a population-based study based on the clinical practice. 61
19529998 2009
303
[Phenotypic characterization of yeasts isolated from the vaginal mucosa of adult women]. 61
19578672 2009
304
[Prevalence and characterization of vaginal lactobacillus species in women at reproductive age without vulvovaginitis]. 61
19578674 2009
305
Urologic issues in the pediatric and adolescent gynecology patient. 61
19344848 2009
306
[Factors associated with bacteriuria after indwelling urethral catheterization in gynecologic surgery]. 61
19488655 2009
307
[The role of streptococci in psoriasis]. 61
19151963 2009
308
[Infectious pathology: vulvovaginitis, sexually transmitted diseases, pelvic inflammatory disease, tubo-ovarian abscesses]. 61
19436336 2009
309
[The relation between trichomoniasis and contraceptive methods]. 61
20101574 2009
310
Microbiological findings in prepubertal girls with vulvovaginitis. 61
20021979 2009
311
Isolation of Porphyromonas levii from vaginal samples from cows in herds negative for bovine necrotic vulvovaginitis. 61
19103617 2008
312
Validation of betapropiolactone (BPL) as an inactivant for infectious bovine rhinotracheitis (IBR) virus. 61
18262212 2008
313
Prevalence of vulvovaginitis and bacterial vaginosis in patients with koilocytosis. 61
19274321 2008
314
A study of abdominal pain in children. 61
19079393 2008
315
Group A Streptococcus vulvovaginitis in breastfeeding women. 61
18674653 2008
316
[Ketoconazole and clindamycin efficacy vs oral clindamycin in premature membranes rupture prevention]. 61
18798437 2008
317
[Study on vaginal production of human defensins and the correlated pathogenetic factors of vulvovaginal candidiasis]. 61
19080508 2008
318
Determining the cause of vulvovaginal symptoms. 61
18559121 2008
319
McGill pain questionnaire findings among women with vulvodynia and chronic yeast infection. 61
18664053 2008
320
Lactational amenorrhea as a risk factor for group a streptococcal vaginitis. 61
18419476 2008
321
Effects of bovine necrotic vulvovaginitis on productivity in a dairy herd in Israel. 61
17433735 2008
322
Isolation of caprine herpesvirus 1 from a major outbreak of infectious pustular vulvovaginitis in goats. 61
18363987 2008
323
[Recurrent vulvovaginitis: diagnostic assessment and therapeutic management]. 61
18358194 2008
324
[Preliminary evaluation of a vaginal cream containing lactoferrin in the treatment of vulvovaginal candidosis]. 61
18487962 2008
325
Herpetiform genital lesions in a heifer with mucosal disease. 61
18424837 2008
326
[Vaginal infections in human immunodeficiency virus-infected women]. 61
19145379 2008
327
Urinary retention in adults: diagnosis and initial management. 61
18350762 2008
328
[Multidisciplinary approach to the management of vulvovaginal discomfort]. 61
18318395 2008
329
2,3,7,8-Tetrachlorodibenzo-p-dioxin increases Bovine Herpesvirus type-1 (BHV-1) replication in Madin-Darby Bovine Kidney (MDBK) cells in vitro. 61
17516555 2008
330
The missing "Bratz" doll: a case of vaginal foreign body. 61
18091600 2007
331
Vulvovaginal candidiasis and its related factors in diabetic women. 61
18182346 2007
332
Bladder and bowel symptoms among women with vulvar disease: are they universal? 61
18210896 2007
333
Comparison of two types of dipsticks to measure vaginal pH in clinical practice. 61
16952417 2007
334
Streptococcus pyogenes pharyngeal colonization resulting in recurrent, prepubertal vulvovaginitis. 61
17868900 2007
335
Prevalence & susceptibility to fluconazole of Candida species causing vulvovaginitis. 61
18037716 2007
336
Hypersensitivity to aeroallergens in patients with recurrent vulvovaginitis of undetermined etiology. 61
17688617 2007
337
[Study on the pathogens correlated to sexually transmitted diseases in 285 pre-pubertal girls with vulvovaginitis in Beijing]. 61
18080562 2007
338
[Evaluation of the antifungal effect of a new propiconazole derivative against 64 yeast strains isolated from vaginal mycosis]. 61
18293715 2007
339
Sample-based assessment of the microbial etiology of bovine necrotic vulvovaginitis. 61
17553557 2007
340
Cidofovir is effective against caprine herpesvirus 1 infection in goats. 61
17161474 2007
341
[Hypospadia in females]. 61
17722617 2007
342
Pregnancy outcome in HIV-positive women in Enugu, Nigeria. 61
17464809 2007
343
Recurrent group A streptococcal vulvovaginitis in adult women: family epidemiology. 61
17278047 2007
344
Bovine herpesvirus 1 infection and infectious bovine rhinotracheitis. 61
17257569 2007
345
Necrotic vulvovaginitis in dairy cattle in Israel. 61
17277301 2007
346
[Correlation between clinical characteristics and mycological tests in the vulvovaginitis by Candida]. 61
17542254 2007
347
Frequency of cervical intraepithelial neoplasia and infectious agents for vaginitis in menstrual cycle phase. 61
17966219 2007
348
[Vulvovaginitis. Occurrence and importance of mixed and unclassifiable pictures]. 61
17357347 2007
349
Epidemiology and eradication of infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV) virus in Finland. 61
17222341 2007
350
Distribution of Candida species in women with vulvovaginal symptoms and their association with different ages and contraceptive methods. 61
17577822 2007
351
Acute vulvovaginitis. 61
17192550 2006
352
Detection of Candida species by PCR in self-collected vaginal swabs of women after taking antibiotics. 61
17022774 2006
353
[Vulvovaginitis: correlation with predisposing factors, clinical manifestations and microbiological studies]. 61
17370572 2006
354
Clinical practice. Acute vulvovaginitis. 61
16990387 2006
355
Two cases of group A streptococcal vulvovaginitis in premenopausal adults in a sexual health setting. 61
17044225 2006
356
Shigella vulvovaginitis in a prepubertal child. 61
16912629 2006
357
[Study on causes and treatment of repeated vulvovaginitis in girlhood]. 61
17083809 2006
358
Vulvovaginal candidiasis from non-albicans species: retrospective study of recurrence rate after fluconazole therapy. 61
16846086 2006
359
Plasma cell vulvovaginitis--a further case. 61
16753706 2006
360
Stress as a cause of chronic recurrent vulvovaginal candidosis and the effectiveness of the conventional antimycotic therapy. 61
16681811 2006
361
[Ofuji's diseases and pregnancy. A report of a case]. 61
16886758 2006
362
Pro and contra IBR-eradication. 61
16337098 2006
363
Vulvovaginitis. 61
16510554 2006
364
Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women. 61
16519751 2006
365
Throwing the dice for the diagnosis of vaginal complaints? 61
16503990 2006
366
[Isolation of group A beta-hemolytic Streptococcus in children with perianal dermatitis]. 61
16527068 2006
367
Childhood vulvovaginitis: report of two cases. 61
17016969 2006
368
Epidemiological study on vaginal Candida glabrata isolated from pregnant women. 61
16338838 2006
369
[Paediatric and adolescence gynaecology in Czech Republic]. 61
16921784 2006
370
Human seminal plasma allergy and successful pregnancy. 61
17039672 2006
371
[Meningococcal vulvovaginitis in a prepubertal girl]. 61
16236488 2005
372
[Congenital cutaneous candidiasis: a case report and review]. 61
16425712 2005
373
Phenotypic and genotypic evaluation of fluconazole resistance in vaginal Candida strains isolated from HIV-infected women from Brazil. 61
16396250 2005
374
Signs of chronic stress in women with recurrent candida vulvovaginitis. 61
16202729 2005
375
Child sexual abuse examination: is there a need for routine screening for N gonorrhoeae and C trachomatis? 61
16202938 2005
376
Management of cervical incompetence in Aba, south-eastern Nigeria. 61
16353700 2005
377
[Chronic urticaria: clinical characteristics of a group of patients of Veracruz, Mexico]. 61
16579183 2005
378
[Antifungal effect in selected natural compounds and probiotics and their possible use in prophylaxis of vulvovaginitis]. 61
16180802 2005
379
Vulvovaginitis and vaginal discharge in the pediatric patient. 61
16126111 2005
380
Vulvovaginitis and perineal cellulitis due to group a streptococcus in an adult woman. 61
15967936 2005
381
The epidemiology of mycotic vulvovaginitis and the use of antifungal agents in suspected mycotic vulvovaginitis and its implications for clinical practice. 61
16209225 2005
382
[Vaginal swab in pediatric age]. 61
16910456 2005
383
[Comparative study between female adolescents with and without sexually transmitted diseases]. 61
16007300 2005
384
Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. 61
15872235 2005
385
["Mixed" and "miscellaneous" vulvovaginitis: diagnostics and therapy of vaginal administration of nystatin and nifuratel]. 61
16047929 2005
386
Group B streptococcal vaginitis in postpubertal adolescent girls. 61
15837348 2005
387
Recurrent vulvovaginitis candidiasis; an overview of traditional and alternative therapies. 61
15898312 2005
388
[Vulvovaginal candidiasis: a therapeutic approach]. 61
15940073 2005
389
Costs associated with the management of overactive bladder and related comorbidities. 61
15977912 2005
390
Enzyme production and biotypes of vaginal Candida albicans. 61
16450839 2005
391
Do we need to treat vulvovaginitis in prepubertal girls? 61
15661783 2005
392
[Vulvovaginitis: vaginal pH changes and associated microflora]. 61
17768818 2005
393
Candida Vulvovaginitis in Pregnancy. 61
15538981 2004
394
[Study of acute vulvovaginitis in sexually active adult women, with special reference to candidosis, in patients of the Francisco J. Muñiz Infectious Diseases Hospital]. 61
15709796 2004
395
[Vulvovaginitis in childhood]. 61
15697083 2004
396
Mycoplasma species and related organisms isolated from ruminants in Britain between 1990 and 2000. 61
15508840 2004
397
Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial. 61
15333452 2004
398
"White dots on the placenta and red dots on the baby": congential cutaneous candidiasis--a rare disease of the neonate. 61
15303819 2004
399
[Preliminary results of the Italian epidemiological study on vulvo-vaginitis]. 61
15258544 2004
400
Fenticonazole nitrate for treatment of vulvovaginitis: efficacy, safety, and tolerability of 1-gram ovules, administered as ultra-short 2-day regimen. 61
15216954 2004
401
A growing concern: inability to diagnose vulvovaginal infections correctly. 61
15051575 2004
402
Bovine necrotic vulvovaginitis associated with Porphyromonas levii. 61
15109423 2004
403
Group A beta-hemolytic streptococcal vulvovaginitis: diagnosis by rapid antigen testing. 61
15024442 2004
404
[Antifungal immunity and its mechanism in female genitalia]. 61
15141525 2004
405
The PAV trial: does lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Protocol of a randomised controlled trial [ISRCTN24141277]. 61
15046642 2004
406
[A case of urethral transposition and vaginoplasty in the presence of urogenital sinus in women]. 61
15114760 2004
407
Diabetes mellitus in pregnancy in an African population. 61
14871512 2004
408
[Genital infections in women, in community practice. Comparison of two studies, 1987 and 2002]. 61
15620021 2004
409
The aetiology of paediatric inflammatory vulvovaginitis. 61
14655013 2004
410
The importance of diagnostic work-up in the management of candidal vulvovaginitis. A prospective study. 61
15266763 2004
411
[Vaginal ecosystem]. 61
15673027 2004
412
Infections of the lower female genital tract during childhood and adolescence. 61
15491059 2004
413
The detection of urinal neopterin concentration increases the efficiency of cervical smear in the diagnosis of cervical cancer. 61
15446363 2004
414
[Aspects of the children's candidiasis in outpatient practice]. 61
15688774 2004
415
[Genital infections in girls with type 1 diabetes]. 61
15318538 2004
416
Fungal infections of urogenital system. 61
15075041 2004
417
Erosive Vulvovaginitis. 61
14642191 2003
418
Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis. 61
14709186 2003
419
Bovine herpesvirus 1 interferes with TAP-dependent peptide transport and intracellular trafficking of MHC class I molecules in human cells. 61
14551822 2003
420
Sexually transmitted diseases, HIV, and AIDS in women. 61
14621327 2003
421
Lichen planus and the vulvovaginal-gingival syndrome. 61
14584875 2003
422
"Not thrush again!" Women's experience of post-antibiotic vulvovaginitis. 61
12831384 2003
423
[Biology of bovine herpesviruses]. 61
12784548 2003
424
Vulvovaginitis in prepubertal girls. 61
12651758 2003
425
Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance. 61
12621787 2003
426
Clinical study on the dose-effect relationship of a nifuratel-nystatin combination in the treatment of vulvo-vaginal infections. 61
14650366 2003
427
Relationship of fungal vaginitis therapy to prior antibiotic exposure. 61
15022876 2003
428
Sexually transmitted infections associated with vulvovaginal symptoms in adolescents denying sexual activity. 61
14974275 2003
429
Clinical and microbiological features of Haemophilus influenzae vulvovaginitis in young girls. 61
12461068 2002
430
[Recurrent abdominal pain and genital diseases in young girls]. 61
14974228 2002
431
Differential characterization of women with vulvar vestibulitis syndrome. 61
12237632 2002
432
[Comment on "Recommendations for diagnosis and therapy of vulvovaginitis"]. 61
12434670 2002
433
[Genital infections in prepubertal girls]. 61
12369152 2002
434
[Enterobiasis among schoolchildren in a rural population from Estado Falcón, Venezuela, and its relation with socioeconomic level]. 61
12229279 2002
435
Premenarchal vaginal discharge: findings of procedures to rule out foreign bodies. 61
12459229 2002
436
Vulvovaginitis due to fluconazole resistant Candida albicans following self treatment with non-prescribed triazoles. 61
12181480 2002
437
[Clinical and experimental study on effect of jietongyin lotion in treating vulvovaginitis in young girls]. 61
12572379 2002
438
Microbiology and management of polymicrobial female genital tract infections in adolescents. 61
12459228 2002
439
Atrophic vulvovaginitis in women aged 50 years and above, both current and non-users of hormone replacement therapy, attending a genitourinary medicine clinic. 61
16259830 2002
440
Boric acid susceptibility testing of non-C. albicans Candida and Saccharomyces cerevisiae: comparison of three methods. 61
12146764 2002
441
The pathogenetic significance of intestinal Candida colonization--a systematic review from an interdisciplinary and environmental medical point of view. 61
12068745 2002
442
[Candidal vulvovaginitis: an epidemiological survey among immigrant prostitutes]. 61
12700439 2002
443
[Recommendations for the diagnosis and therapy of vulvovaginitis]. 61
11987578 2002
444
[Vulvovaginitis caused by Candida spp. and Trichomonas vaginalis in sexually active women]. 61
11921745 2002
445
Chronic vulvovaginitis caused by antibiotic-resistant Shigella flexneri in a prepubertal child. 61
11840089 2002
446
[Efficacy and tolerance of 200 mg of fenticonazole versus 400 mg of miconazole in the intravaginal treatment of mycotic vulvovaginitis]. 61
12017948 2002
447
Assessment of vulvovaginal complaints: accuracy of telephone triage and in-office diagnosis. 61
11777504 2002
448
Karyotyping of Candida albicans and Candida glabrata isolates from recurrent vaginal infections by pulsed-field gel electrophoresis. 61
12073826 2002
449
Clinical trial comparing the activity and efficacy of ibuprofen isobutanolammonium vs Benzydamine hydrochloride, applied as vaginal irrigations, in patients with vaginitis. 61
12519036 2002
450
Antimicrobial Resistance in Vulvovaginitis. 61
11722813 2001
451
Vulval disease in pre-pubertal girls. 61
11903151 2001
452
[Perihepatitis and HIV/AIDS infection. Apropos of 13 cases at the National Hospital of Bobo-Dioulasso]. 61
11845526 2001
453
Advances in BHV1 (IBR) research. 61
11721589 2001
454
Menopause and the skin. 61
11488706 2001
455
Recurrent vulvovaginal candidiasis. 61
12112949 2001
456
[Vulvar vestibulitis syndrome as an important clinical problem]. 61
11599256 2001
457
[Prevalence of sexually transmitted diseases and the use of the condom among sex workers]. 61
11599316 2001
458
A retrospective analysis of the infectious bovine rhinotracheitis (bovine herpes virus-1) surveillance program in Norway using Monte Carlo simulation models. 61
11448499 2001
459
Severe vulvovaginitis associated with intravaginal nystatin therapy. 61
11483943 2001
460
Allergic vulvovaginitis in infancy: study of a case. 61
11674928 2001
461
Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. 61
11378043 2001
462
[Comparative evaluation of clinical, cytological and cell culture methods of candida vulvovaginitis diagnosis]. 61
11452655 2001
463
Continous flow vaginoscopy in children. 61
17043581 2001
464
The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. 61
11237825 2001
465
The Bali STD/AIDS study: association between vaginal hygiene practices and STDs among sex workers. 61
11158691 2001
466
[Vulvovaginal candidiasis in childhood--diagnostic and therapeutic results]. 61
11799748 2001
467
Candida lusitaniae as an unusual cause of recurrent vaginitis and its successful treatment with intravaginal boric acid. 61
11916183 2001
468
Susceptibility profile of vaginal yeast isolates from Brazil. 61
11502064 2001
469
We, specialists in vulvovaginitis. 61
11174523 2001
470
Differentiation between women with vulvovaginal symptoms who are positive or negative for Candida species by culture. 61
11916179 2001
471
The classic approach to diagnosis of vulvovaginitis: a critical analysis. 61
11495550 2001
472
Acute glomerulonephritis with group A streptococcal vulvovaginitis. 61
11156071 2000
473
Topical treatment of vaginal candidosis with sertaconazole and econazole sustained-release suppositories. 61
11118564 2000
474
Vaginal candidosis: epidemiological and etiological factors. 61
11118561 2000
475
Ureaplasma diversum and reproductive disorder in Brazilian cows and heifers; first report. 61
10989224 2000
476
Continuous-flow vaginoscopy in children and adolescents. 61
11044506 2000
477
Allergic vulvovaginitis. 61
11061467 2000
478
Constipation presenting as recurrent vulvovaginitis in prepubertal children. 61
11004639 2000
479
Microperforate hymen at 27 years of age diagnosed with withdrawal bleeding and hysterofiberscopy. 61
10985624 2000
480
Sexual behaviors and other risk factors for Candida vulvovaginitis. 61
10957753 2000
481
Combined contact allergy to tea tree oil and lavender oil complicating chronic vulvovaginitis. 61
10789871 2000
482
[Mucocutaneous candidosis in a patient with Sjögren syndrome]. 61
10868017 2000
483
Herpes simplex virus type 1 as a cause of widespread intracorneal blistering of the lower limbs. 61
10733634 2000
484
[Vulvodynia]. 61
10789074 2000
485
Vulvar disease in children: a clinical audit of 130 cases. 61
10720979 2000
486
[Causes for healing complications in episiotomy]. 61
11288625 2000
487
Value of Candida polymerase chain reaction and vaginal cytokine analysis for the differential diagnosis of women with recurrent vulvovaginitis. 61
11220486 2000
488
[Cesarean section in modern obstetrics and methods of prophylaxis of postoperative sepsis]. 61
11187992 2000
489
Semiquantitative bacterial observations with group B streptococcal vulvovaginitis. 61
10968592 2000
490
Vulvovaginitis: clinical features, aetiology, and microbiology of the genital tract. 61
10373139 1999
491
Epitopes on glycoprotein C of bovine herpesvirus-1 (BHV-1) that allow differentiation between BHV-1.1 and BHV-1.2 strains. 61
10374966 1999
492
Current evaluation and management of vulvovaginitis. 61
10370840 1999
493
Vulvovaginitis in healthy women. 61
10470518 1999
494
Primary Sjögren's syndrome in children and adolescents: proposal for diagnostic criteria. 61
10410277 1999
495
Vulvodynia and vulvar vestibulitis: challenges in diagnosis and management. 61
10193596 1999
496
Vaginal heat shock protein expression in symptom-free women with a history of recurrent vulvovaginitis. 61
10076122 1999
497
Isolation of Corynebacterium pilosum and Actinomyces pyogenes from cystitis and vulvovaginitis infection in a 2-month-old female calf. 61
10216455 1999
498
Human parvovirus B19-associated disease in bone marrow transplantation. 61
10219641 1999
499
Vulvovaginitis secondary to examination with latex rubber gloves. 61
15512277 1999
500
Combined oral and vaginal treatment of severe vulvovaginitis during childhood. 61
9929836 1999
501
Semiquantitative bacterial observations with group B streptococcal vulvovaginitis. 61
10524667 1999
502
Susceptibility of Candida species isolated from female prostitutes with vulvovaginitis to antifungal agents and boric acid. 61
10192716 1999
503
Circulating heat shock proteins in women with a history of recurrent vulvovaginitis. 61
10371470 1999
504
[The interrelations of genital lesions-urinary tract infections in girls]. 61
10756894 1999
505
A diagnostic in vitro urine assay for interstitial cystitis. 61
9836539 1998
506
[Vulvar edema in pregnancy]. 61
10224778 1998
507
[Comparative analysis of general and local immunoreactivity in patients with chronic vulvovaginitis of mixed etiology]. 61
9949504 1998
508
STD interactive case challenge--diagnosing and treating chronic vulvar pain and erythema. 61
9878923 1998
509
Vulvovaginitis. When Candida becomes a problem. 61
9891677 1998
510
Vulvovaginal candidiasis in female sex workers. 61
9764936 1998
511
Herpes simplex virus. 61
9738993 1998
512
Assessment of vulvovaginal complaints: agreement between phone and office management. 61
10838281 1998
513
[Warning against a fashionable cure for vulvovaginitis. Tea tree oil may substitute Candida itching with allergy itching]. 61
9715070 1998
514
[The role of vaginal pH. Importance of its normalization in the prevention of recurrent vaginitis]. 61
9763819 1998
515
[Proliferative response and suppressor activity of lymphocytes in candidiasis]. 61
9700883 1998
516
Pinworms and postmenopausal bleeding. 61
9708211 1998
517
Allergic vulvovaginitis induced by house dust mites: a case report. 61
9564812 1998
518
Index of suspicion. Case 3. Diagnosis: vulvovaginitis. 61
9473943 1998
519
[A case of labial adhesions in an elderly woman]. 61
9546137 1998
520
Female genital tract bacterial coisolates with Candida albicans in patients without clinical vaginitis. 61
9702585 1998
521
Vulvovaginitis due to Candida glabrata. An emerging problem. 61
10085680 1998
522
Studies on mycotoxins in the Kruger National Park region, Eastern Transvaal--with special respect to the abolition of recurrent myco-oestrogen abortion and vulvo-vaginitis in the large Piggery. 61
9502239 1998
523
Progression of intravaginal infection by herpes simplex-2 in genetically athymic mice. 61
9922482 1998
524
[Modern aspects in the diagnosis and treatment of gynecologic diseases in childhood and adolescence]. 61
9471518 1997
525
Prevalence and susceptibility of vaginal yeast isolates in Jordan. 61
9476485 1997
526
[Mycotic vulvovaginitis]. 61
9471643 1997
527
[Vulvovaginitis]. 61
9406511 1997
528
Treatment of vaginal infections: candidiasis, bacterial vaginosis, and trichomoniasis. 61
9479409 1997
529
Haemophilus influenzae: an underrated cause of vulvovaginitis in young girls. 61
9389978 1997
530
Immune compromise and prevalence of Candida vulvovaginitis in human immunodeficiency virus-infected women. 61
9241304 1997
531
[Candida albicans vulvovaginitis--trends in care and implications]. 61
9332057 1997
532
Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy. 61
9258552 1997
533
[Review of the latest treatments of vulvovaginal mycoses: role of fenticonazole nitrate (Lomexin) in their treatment]. 61
9273113 1997
534
Pharmacologic management of sexually transmitted diseases. 61
9239973 1997
535
Group B streptococcal vulvovaginitis. 61
9204033 1997
536
Infectious pustular vulvovaginitis/infectious pustular balanoposthitis in cattle. 61
9194305 1997
537
Pediatric vulvo-vaginitis. 61
9103956 1997
538
Vulvovaginitis during childhood and adolescence. 61
9061634 1997
539
Ultrastructural changes of Candida albicans under influence of cyclosporin A. 61
9646704 1997
540
A contribution to the systematization of bovine herpesvirus 1 based on genomic mapping by restriction fragment pattern analysis. 61
9029790 1996
541
Incidence of pelvic inflammatory disease among women treated for gonorrhea or chlamydia. 61
15073812 1996
542
[Vulvovaginitis]. 61
8978203 1996
543
Childhood vulvovaginitis and vaginal discharge in general practice. 61
8872094 1996
544
Serological and virological studies on the infectious bovine rhinotracheitis in Algeria. 61
8767771 1996
545
Hysteroscopic extraction of a vaginal foreign body in a child. 61
9050672 1996
546
[Microbiological study of vulvovaginitis in premenarcheal girls]. 61
8744372 1996
547
Immunological investigations in vaginal mycoses. 61
8909027 1996
548
Most frequent scenario for recurrent Candida vaginitis is strain maintenance with "substrain shuffling": demonstration by sequential DNA fingerprinting with probes Ca3, C1, and CARE2. 61
8815082 1996
549
Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus. 61
8729224 1996
550
Child sexual abuse examination: is there a need for routine screening for N. gonorrhoeae? 61
8795782 1996
551
Short-course itraconazole in the treatment of candida vulvovaginitis: A multicentre Canadian study. 61
22514427 1996
552
Candida vulvovaginitis. 61
8723820 1996
553
[Nifuratel and nystatin combination therapy in vulvovaginitis of mixed etiology in children and adolescents]. 61
8624598 1996
554
[Makmiror-complex in the treatment of post-radiation infectious vulvovaginitis in cancer patients]. 61
9123907 1996
555
Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses. 61
18476097 1996
556
[Bacteriology of vulvo-vaginitis in pediatrics]. 61
9827107 1996
557
Once-daily fluocinonide-bifonazole combination for the treatment of vulvar itching and vulvovaginal candidiasis. Preliminary study. 61
8894328 1996
558
Vulvar vestibulitis-a complex clinical entity. 61
18476106 1996
559
The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products. 61
8537226 1995
560
Association of recurrent candidal vaginitis with inheritance of Lewis blood group antigens. 61
7594730 1995
561
Paediatric vulvovaginitis. 61
8593114 1995
562
Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida. 61
7490047 1995
563
Genitourinary infection in older women. 61
8551375 1995
564
Virulence and genotype of a bovine herpesvirus 1 isolate from semen of a subclinically infected bull. 61
8533214 1995
565
Vulvovaginitis in the prepubertal child. 61
7562313 1995
566
The high vaginal swab in general practice: clinical correlates of possible pathogens. 61
7589937 1995
567
Diagnosis and treatment of vulvodynia. 61
7632410 1995
568
Vulvodynia--a complex syndrome of vulvar pain. 61
7732794 1995
569
Genital bleeding in premenarcheal children. 61
9457983 1995
570
[Leukorrhea in adolescents: an underestimated problem]. 61
7610078 1995
571
Severe vaginal infection with Entamoeba histolytica in a woman who recently returned from Mexico: case report and review. 61
7756499 1995
572
Tuboovarian abscess associated with Candida glabrata in a woman with an intrauterine device. A case report. 61
7776309 1995
573
[Osteoarticular infections caused by Streptococcus agalactiae. Report of 4 cases]. 61
7711134 1995
574
Vulvo-vaginitis and reproduction. 61
7736644 1995
575
[Itraconazole in the treatment of Candida vulvovaginitis in patients with type II diabetes mellitus (non-insulin dependent)]. 61
7896149 1995
576
Transhymenal cultures for sexually transmissible organisms. 61
7826112 1994
577
[Candida vulvovaginitis]. 61
7996909 1994
578
[Cetyltrimethylammonium naproxenate as vaginal lavage in the therapy of vulvovaginal dystrophies in the postmenopause]. 61
7838418 1994
579
Incidence, species distribution and antifungal sensitivity pattern of vaginal yeasts in Sri Lankan women. 61
7746296 1994
580
[Vulvo-cervico-vaginal inflammatory pathologies in childhood and adolescence. Our experience]. 61
7984324 1994
581
Pathology of the vulva and vagina. 61
7742499 1994
582
Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive women. 61
7959713 1994
583
Long-acting injectable contraception with depot medroxyprogesterone acetate. 61
8178904 1994
584
The value of prophylactic (monthly) clotrimazole versus empiric self-treatment in recurrent vaginal candidiasis. 61
8206471 1994
585
[Vulvar vestibulitis]. 61
8015696 1994
586
Methods of contraception and rates of genital infections. 61
8070115 1994
587
Persistent vulvovaginal candidiasis: systemic treatment with oral fluconazole. 61
7994878 1994
588
The concept of immune-based therapies in chronic viral infections. 61
8182508 1994
589
Systemic treatment of recurrent candidal vulvovaginitis by Itraconazole. 61
8020181 1994
590
Streptococcal vulvovaginitis in girls. 61
8302742 1993
591
[Vulvo-vaginitis in pediatric age]. 61
8133837 1993
592
Reproductive performance of beef heifers: effects of vulvo-vaginitis, Ureaplasma diversum and prebreeding antibiotic administration. 61
16727333 1993
593
Application of biotyping and DNA typing of Candida albicans to the epidemiology of recurrent vulvovaginal candidiasis. 61
8101553 1993
594
Clinical manifestations of infection with the human immunodeficiency virus in women in Louisiana. 61
8399861 1993
595
[Vulvovaginitis in girls. I. Characteristics of the investigated population]. 61
8375710 1993
596
[Fluconazole in the treatment of vaginitis caused by Candida albicans]. 61
8414146 1993
597
[Vulvovaginitis in girls. II. Microbiology of the vagina]. 61
8375711 1993
598
[Vulvovaginitis in girls. III. Clinical manifestations and efficiency of therapy]. 61
8375712 1993
599
[Trial of characterizing bacterial strains isolated from vaginal discharge of girls]. 61
8375708 1993
600
Vaginal infections: diagnosis and management. 61
8498288 1993
601
Premenarchal vulvovaginitis. 61
8515042 1993
602
[Frequency of vaginal trichomoniasis and candidiasis and its relation to the clinical profile]. 61
8209117 1993
603
Vulvovaginitis in the child and adolescent. 61
8516239 1993
604
Management of vulvovaginitis in pregnancy. 61
8435943 1993
605
The management of obscure or difficult cases of vulvovaginitis. 61
8435944 1993
606
The identification of Mycoplasma mycoides mycoides LC as the aetiological agent of balanoposthitis and vulvovaginitis in sheep in South Africa. 61
8392679 1993
607
Streptococci and the genital tract. 61
8476967 1993
608
Candidal vulvovaginitis. 61
8435940 1993
609
[Clinical results of pediatric gynecologic consultation at the Heidelberg University Gynecologic Clinic]. 61
8451893 1993
610
Vulvar and vaginal disorders. 61
1333291 1992
611
[Comparative clinical study of a new imidazole molecule (fluconazole) and ketaconazole in the treatment of Candida albicans vulvovaginitis]. 61
1491774 1992
612
Vulvovaginitis and vaginal pH. 61
1489239 1992
613
Vulvovaginitis. 61
1489237 1992
614
Sexually transmitted diseases in children. 61
1492047 1992
615
Evaluation of new anti-infective drugs for the treatment of vaginal infections. Infectious Diseases Society of America and the Food and Drug Administration. 61
1477218 1992
616
Shigella and gonococcal vulvovaginitis in prepubertal central African girls. 61
1408494 1992
617
[Practice observations of cross protection between bovine and porcine herpesviruses]. 61
1332217 1992
618
Vulvovaginal conditions: social, psychological, and sexual considerations. 61
1472892 1992
619
Vulvovaginitis: promotion of condom use to prevent sexually transmitted disease. 61
1472891 1992
620
Cytolytic vaginosis: a common cause of cyclic vulvovaginitis. 61
1472886 1992
621
Vulvovaginitis in the prepubertal child. 61
1472887 1992
622
Vulvovaginitis in the postmenopausal woman. 61
1472888 1992
623
Risk factors for Candida vulvovaginitis. 61
1513528 1992
624
Evaluation of a latex agglutination test for the identification of Candida species in vaginal discharge. 61
1496893 1992
625
Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. 61
1350804 1992
626
[The efficacy of pyrantel in vulvovaginitis of enterobiasis etiology]. 61
1435565 1992
627
[Comparison of methods of treatment in mycotic vulvovaginitis]. 61
1628339 1992
628
Vulvovaginitis: causes and management. 61
1580682 1992
629
[Microbiological evaluation of the effectiveness of gynalgin in the treatment of vaginitis]. 61
1462586 1992
630
Recurrent vaginal candidiasis. Results of a cohort study of sexual transmission and intestinal reservoir. 61
1593559 1992
631
Vulvovaginitis. 61
1606764 1992
632
Prepubertal vulvovaginopathies. 61
1584544 1992
633
Activity and tolerability of tetridamine vaginal lavage in rats and women. 61
1418890 1992
634
[Current chemotherapy in urogenital infections. 6: antibiotics during pregnancy and lactation in urethro-adnexitis, vulvovaginitis and cervicitis]. 61
1607139 1992
635
Penicillinase-producing Neisseria gonorrhoeae conjunctivitis on some Nigerian children. 61
1300358 1992
636
Fungal vulvovaginitis. 61
1818723 1991
637
[Preliminary clinical study of the use of itraconazole in the treatment of vulvovaginal candidiasis]. 61
1668125 1991
638
Evaluation of herpes simplex virus vaccines in animals: the guinea pig vaginal model. 61
1664129 1991
639
[Vulvovaginitis in premenarche girls. A preliminary study]. 61
1785745 1991
640
Mycotic vulvovaginitis: a broad overview. 61
1951573 1991
641
Vulvovaginitis: causes and therapies. 61
1951570 1991
642
Vulvovaginitis: the role of patient compliance in treatment success. 61
1951576 1991
643
Vulvitis and vulvovaginitis: cutaneous considerations. 61
1659196 1991
644
Vulvovaginitis: diagnosis and management. 61
1769193 1991
645
[Etiology of vulvovaginitis in childhood]. 61
1844941 1991
646
Recurrent vulvovaginitis resulting from Candida species was the heavy dietary use of "artificial sweeteners". 61
1941798 1991
647
Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis. 61
1941801 1991
648
Vaginal bleeding in premenarchal girls: a review. 61
1876356 1991
649
Streptococcus pyogenes vulvovaginitis in children in Nottingham. 61
2050200 1991
650
Chronic vulvovaginitis in a 30-year-old woman. 61
2035900 1991
651
Allergy to coitus. 61
1681800 1991
652
[Refractory vaginal candidiasis]. 61
2069686 1991
653
[Differentiation of strains of bovine infectious rhinotracheitis virus using restriction analysis]. 61
1649969 1991
654
Recurrent vaginitis. 61
2048988 1991
655
[Presenile and senile vulvovaginitis. Topical hormonal treatment with estriol]. 61
1857515 1991
656
Psychosocial aspects of chronic, clinically unconfirmed vulvovaginitis. 61
2053947 1991
657
Congenital cutaneous candidiasis: report of four cases and review of the literature. 61
2044606 1991
658
Sero-prevalences of selected cattle diseases in the Kafue flats of Zambia. 61
1646515 1991
659
Comparison of topical fungicides in women suffering from vulvovaginitis. 61
1818427 1991
660
A study of some biologic properties of Bovid herpesvirus-4. 61
1657513 1991
661
Gynaecological infections and strategies for treatment. 61
2075077 1990
662
Terconazole for the treatment of vulvovaginal candidiasis. 61
2277372 1990
663
Group A beta-hemolytic streptococcal vulvovaginitis in prepubertal girls: a case report and review of the past twenty years. 61
2263434 1990
664
Psychosocial aspects of chronic, clinically unconfirmed vulvovaginitis. 61
2098014 1990
665
Office Approach to Urethritis, Vaginitis, and Cervicitis in Adolescents. 61
10350729 1990
666
[Effects and side effects of estrogens and gestagens in pediatric and adolescent gynecology]. 61
2079940 1990
667
Pap smear examinations of women at the out-patient department of Siriraj Hospital. 61
2262751 1990
668
[CMV virus infection of the vulva and vagina]. 61
2177017 1990
669
Is candidiasis the true cause of vulvovaginal irritation in women with diabetes mellitus? 61
2131794 1990
670
[A clinical study of cyclopyroxolamine versus clotrimazole in the treatment of mycotic vulvovaginitis]. 61
2199853 1990
671
Round table on infectious bovine rhinotracheitis/infectious pustular vulvovaginitis virus infection diagnosis and control. 61
2402878 1990
672
Gynecological abnormalities following allogeneic bone marrow transplantation. 61
2369683 1990
673
Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. 61
2197091 1990
674
Clinical and mycological spectrum of cutaneous candidiasis in Bombay. 61
2097373 1990
675
Evaluation of pregnant rabbits as a laboratory model for bovid herpesvirus-4 infection. 61
2158255 1990
676
[Urogenital chlamydial infection in men and their sexual contacts]. 61
2340559 1990
677
An outbreak of granulomatous vulvitis in feedlot heifers. 61
2269990 1990
678
Recurrent allergic vulvovaginitis: treatment with Candida albicans allergen immunotherapy. 61
2178425 1990
679
Different antibody response against Candida albicans cell wall antigens in cervicovaginal secretions of patients with vulvovaginal candidiasis. 61
2265804 1990
680
[The role of the mycocenosis due to Candida albicans and the herpes simplex virus type II in urethritis and vulvovaginitis]. 61
2175070 1990
681
Interest of biotyping Candida albicans in chronic vulvovaginitis. 61
2188128 1990
682
A comparison of polypeptides and restriction endonuclease sites of BHV-1 isolates and identification of IPV virus in Japan. 61
2557474 1989
683
The semantics of diagnosis and management of genitourinary infections: a cross-specialty study. 61
2632305 1989
684
Prevalence of asymptomatic carriers of Chlamydia trachomatis among pregnant and non-pregnant women in south-western Greece. 61
2606182 1989
685
Prevalence of bovid herpesvirus-4 and its antibody in cattle in Minnesota. 61
2559632 1989
686
The association between dietary intake and reported history of Candida vulvovaginitis. 61
2553850 1989
687
Diagnosis of Candida vulvovaginitis. 61
2769185 1989
688
[General and advanced aspects of treatment of vulvovaginal mycosis]. 61
2688319 1989
689
Culture-positive persistence and serum agglutinating antibody response after intrauterine inoculation of Haemophilus somnus in virgin heifers. 61
2774318 1989
690
[Treatment of vulvovaginitis in girls]. 61
2802064 1989
691
Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis. 61
2671362 1989
692
Vaginal infections. 61
21248968 1989
693
[Ciclopiroxolamine in the topical treatment of vaginal mycoses]. 61
2771141 1989
694
Lack of specificity of Chlamydiazyme for detection of vaginal chlamydial infection in prepubertal girls. 61
2487781 1989
695
Vulvovaginitis and cervicitis. 61
2660084 1989
696
Gonorrheal vulvovaginitis, labial fusion and imperforate hymen. 61
2916516 1989
697
Ontario. Ureaplasmal vulvovaginitis and infertility in eight southern Ontario dairy herds. 61
17423268 1989
698
Antibodies against Trichosporon beigelii in vaginal washings from asymptomatic women. 61
2647994 1989
699
[Importance of an antiseptic solution, Solubacter, in vulvo-vaginal infections]. 61
2685972 1989
700
Evaluation and management of vaginitis. An update for primary care practitioners. 61
2645843 1989
701
Clotrimazole treatment of recurrent and chronic candida vulvovaginitis. 61
2644595 1989
702
[Venereal diseases in children and sexual abuse]. 61
2922864 1989
703
In vitro sensitivity of Candida (Torulopsis) glabrata to clotrimazole. 61
2765132 1989
704
Molecular cloning of DNA from a bovine herpesvirus 1 strain isolated in Hungary. 61
2561661 1989
705
Investigations on the role of some viral, chlamydian, rickettsian and mycoplasmic agents in several gynecological diseases. 61
2773311 1989
706
Changes in the bovine herpesvirus 1 genome during acute infection, after reactivation from latency, and after superinfection in the host animal. 61
2549919 1989
707
[The control of infectious bovine rhinotracheitis (IBR) in Switzerland from 1978 to 1988]. 61
2678460 1989
708
[Importance of extragenital diseases in the etiology of vulvovaginitis].